10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________________

FORM 10-Q

___________________________

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended September 30, 2011

OR

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from________ to________ .

Commission File Number: 1-644

COLGATE-PALMOLIVE COMPANY

(Exact name of registrant as specified in its charter)

DELAWARE	13-1815595
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

300 Park Avenue, New York, New York	10022
(Address of principal executive offices)	(Zip Code)

(212) 310-2000

(Registrant’s telephone number, including area code)

NO CHANGES

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes x  No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check One):

Large accelerated filer x	Accelerated filer ¨
Non-accelerated filer ¨	Smaller reporting company ¨

(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

Class	Shares Outstanding	Date
Common stock, $1.00 par value	483,999,297	September 30, 2011

PART I.FINANCIAL INFORMATION

COLGATE-PALMOLIVE COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Dollars in Millions Except Per Share Amounts)

(Unaudited)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2011			2010			2011			2010
Net sales	$	4,383		$	3,943		$	12,562		$	11,586
Cost of sales	1,921			1,599			5,365			4,732
Gross profit	2,462			2,344			7,197			6,854
Selling, general and administrative expenses	1,489			1,391			4,314			4,038
Other (income) expense, net	(62		)	(5		)	(35		)	232
Operating profit	1,035			958			2,918			2,584
Interest expense, net	10			13			37			43
Income before income taxes	1,025			945			2,881			2,541
Provision for income taxes	349			300			952			879
Net income including noncontrolling interests	676			645			1,929			1,662
Less: Net income attributable to noncontrolling interests	33			26			88			83
Net income attributable to Colgate-Palmolive Company	$	643		$	619		$	1,841		$	1,579
Earnings per common share, basic	$	1.32		$	1.26		$	3.76		$	3.17
Earnings per common share, diluted	$	1.31		$	1.21		$	3.73		$	3.07
Dividends declared per common share	$	0.58		$	0.53		$	1.69		$	1.50

See Notes to Condensed Consolidated Financial Statements.

2

COLGATE-PALMOLIVE COMPANY

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in Millions)

(Unaudited)

	September 30, 2011			December 31, 2010
Assets
Current Assets
Cash and cash equivalents	$	945		$	490
Receivables (net of allowances of $52 and $53, respectively)	1,677			1,610
Inventories	1,336			1,222
Other current assets	485			408
Total current assets	4,443			3,730
Property, plant and equipment:
Cost	7,229			7,160
Less: Accumulated depreciation	(3,614		)	(3,467		)
	3,615			3,693
Goodwill, net	2,694			2,362
Other intangible assets, net	1,424			831
Deferred income taxes	91			84
Other assets	501			472
Total assets	$	12,768		$	11,172
Liabilities and Shareholders’ Equity
Current Liabilities
Notes and loans payable	$	67		$	48
Current portion of long-term debt	921			561
Accounts payable	1,150			1,165
Accrued income taxes	379			272
Other accruals	1,800			1,682
Total current liabilities	4,317			3,728
Long-term debt	3,768			2,815
Deferred income taxes	275			108
Other liabilities	1,538			1,704
Shareholders’ Equity
Common stock	733			733
Additional paid-in capital	1,268			1,132
Retained earnings	15,344			14,329
Accumulated other comprehensive income (loss)	(2,199		)	(2,115		)
	15,146			14,079
Unearned compensation	(59		)	(99		)
Treasury stock, at cost	(12,420		)	(11,305		)
Total Colgate-Palmolive Company shareholders’ equity	2,667			2,675
Noncontrolling interests	203			142
Total shareholders’ equity	2,870			2,817
Total liabilities and shareholders’ equity	$	12,768		$	11,172

See Notes to Condensed Consolidated Financial Statements.

3

COLGATE-PALMOLIVE COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in Millions)

(Unaudited)

	Nine Months Ended
	September 30,
	2011			2010
Operating Activities
Net income including noncontrolling interests	$	1,929		$	1,662
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	315			278
Restructuring, net of cash	130			—
Venezuela hyperinflationary transition charge	—			271
Gain before tax on sales of non-core product lines	(207		)	—
Voluntary benefit plan contributions	(178		)	(35		)
Stock-based compensation expense	102			101
Deferred income taxes	134			91
Cash effects of changes in:
Receivables	(127		)	(56		)
Inventories	(147		)	(63		)
Accounts payable and other accruals	62			(95		)
Other non-current assets and liabilities	44			89
Net cash provided by operations	2,057			2,243
Investing Activities
Capital expenditures	(324		)	(318		)
Sale of property and non-core product lines	241			3
Purchases of marketable securities and investments	(108		)	(211		)
Proceeds from sale of marketable securities and investments	173			94
Payment for acquisitions, net of cash acquired	(972		)	—
Other	(8		)	(6		)
Net cash used in investing activities	(998		)	(438		)
Financing Activities
Principal payments on debt	(2,720		)	(3,469		)
Proceeds from issuance of debt	4,074			3,709
Dividends paid	(850		)	(804		)
Purchases of treasury shares	(1,386		)	(1,385		)
Proceeds from exercise of stock options and excess tax benefits	316			204
Net cash provided by (used in) financing activities	(566		)	(1,745		)
Effect of exchange rate changes on Cash and cash equivalents	(38		)	(6		)
Net increase (decrease) in Cash and cash equivalents	455			54
Cash and cash equivalents at beginning of the period	490			600
Cash and cash equivalents at end of the period	945			654
Supplemental Cash Flow Information
Income taxes paid	$	769		$	854

See Notes to Condensed Consolidated Financial Statements.

4

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

1. Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Certain prior year amounts have been reclassified to conform to the current year presentation.

For a complete set of financial notes, including the significant accounting policies of Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”), refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2010, filed with the Securities and Exchange Commission.

2. Use of Estimates

Provision for certain expenses, including income taxes, media advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales.

3. Acquisitions and Divestitures

Sanex Acquisition

On June 20, 2011, the Company, Colgate-Palmolive Europe Sàrl, Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever”) finalized the Company’s acquisition from Unilever of the Sanex personal care business in accordance with a Business and Share Sale and Purchase Agreement (the “Purchase Agreement”) for an aggregate purchase price of €672 ($960), subject to certain post-closing purchase price adjustments. The acquisition was financed with available cash, proceeds from the sale of the Company’s Euro-denominated investment portfolio and the issuance of commercial paper.

Sanex is a personal care brand with a distinct positioning around healthy skin with strong market share positions and 2010 net sales of €187 (approximately $265), primarily in Western Europe.  This strategic acquisition is expected to strengthen Colgate’s personal care business in Europe, primarily in the liquid body cleansing and deodorants businesses.

Total purchase price consideration of $960 has been allocated on a preliminary basis to the net assets acquired based on their respective estimated fair values at June 20, 2011, as follows:

Recognized amounts of assets acquired and liabilities assumed:
Inventories	$	21
Property, plant and equipment, net	7
Other intangible assets, net	605
Goodwill, net	411
Accrued income taxes	(80		)
Long-term other liabilities	(4		)
Fair value of net assets acquired	$	960

Other intangible assets acquired include trademarks of $425 with an indefinite useful life and customer relationships of $180 with useful lives ranging from 12 to 14 years.

Goodwill of $411 was allocated between the Europe/South Pacific segment (95%) and the Greater Asia/Africa segment (5%). The Company expects that substantially all of the goodwill will be deductible for tax purposes.

The preliminary estimates of the fair value of identifiable assets acquired and liabilities assumed are subject to revisions, which may result in adjustments to the preliminary values discussed above.

5

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Pro forma results of operations have not been presented, as the impact on the Company’s consolidated financial statements is not material. The Company expects to finalize the purchase price allocation by the end of 2011. For the nine months ended September 30, 2011, Other (income) expense, net includes $12 in transaction costs related to the acquisition, of which $2 relates to the third quarter.

Pursuant to the Purchase Agreement, Colgate and Unilever also entered into a Transition Services Agreement, under which Unilever agreed to provide certain transitional services in various countries for up to six months following the closing, and a Supply Agreement, pursuant to which Unilever will supply certain Sanex products to Colgate for up to two years following the closing.

Sale of Brands in Colombia

In connection with the Sanex acquisition, Colgate sold its laundry detergent brands in Colombia to Unilever for $215. The detergent sale closed on July 29, 2011 and, as a result of the sale, the Company recognized a pretax gain of $207 ($135 aftertax gain) in the third quarter.

Sale of Land in Mexico

On September 13, 2011, the Company's Mexican subsidiary entered into an agreement to sell the Mexico City site on which its commercial operations, technology center and soap production facility are located. The sale price is payable in three installments, with the final installment due upon the transfer of the property, which is expected to occur in 2014. During the third quarter of 2011, the Company received the first installment of $24 upon signing the agreement. The Company intends to re-invest these payments to relocate its soap production to a new state-of-the-art facility to be constructed at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. As a result, over the next three years, the Company expects to make capital improvements and incur costs to exit the site. These exit costs will primarily be related to staff leaving indemnities, accelerated depreciation and demolition. During the three months ended September 30, 2011, the Company recorded $7 of pretax costs ($5 aftertax costs) related to the sale in Other (income) expense, net.

4. Inventories

Inventories by major class are as follows:

	September 30, 2011		December 31, 2010
Raw materials and supplies	$	324	$	295
Work-in-process	60		50
Finished goods	952		877
Total Inventories	$	1,336	$	1,222

6

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

5. Shareholders’ Equity

Changes in the components of Shareholders’ Equity for the nine months endedSeptember 30, 2011 are as follows:

	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2010	$	733	$	1,132		$	(99	)	$	(11,305	)	$	14,329		$	(2,115	)	$	142
Net income												1,841						88
Other comprehensive income, net of tax															(84		)	(3		)
Dividends												(826		)				(24		)
Stock-based compensation expense			102
Shares issued for stock options			75						222
Shares issued for restricted stock awards			(49		)				49
Treasury stock acquired									(1,386		)
Other			8			40
Balance, September 30, 2011	$	733	$	1,268		$	(59	)	$	(12,420	)	$	15,344		$	(2,199	)	$	203

Accumulated Other comprehensive income (loss), as reflected in the Condensed Consolidated Balance Sheets, primarily consists of cumulative foreign currency translation adjustments and unrecognized pension and other retiree benefit costs. Refer to Note 6 for the components of Other comprehensive income (loss).

6. Comprehensive Income

The following are components of comprehensive income:

	Three Months Ended
	September 30, 2011									September 30, 2010
	Colgate-Palmolive Company			Noncontrolling interests			Total			Colgate-Palmolive Company			Noncontrolling interests		Total
Net income	$	643		$	33		$	676		$	619		$	26	$	645
Other comprehensive income (loss), net of tax:
Cumulative translation adjustment	(478		)	(5		)	(483		)	307			4		311
Retirement Plan and other retiree benefit adjustments	29			—			29			(332		)	—		(332		)
Gains (losses) on cash flow hedges	—			—			—			(3		)	—		(3		)
Other	(2		)	—			(2		)	(5		)	—		(5		)
Total Other comprehensive income (loss), net of tax	$	(451	)	$	(5	)	$	(456	)	$	(33	)	$	4	$	(29	)
Comprehensive income	$	192		$	28		$	220		$	586		$	30	$	616

7

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

	Nine Months Ended
	September 30, 2011									September 30, 2010
	Colgate-Palmolive Company			Noncontrolling interests			Total			Colgate-Palmolive Company			Noncontrolling interests		Total
Net income	$	1,841		$	88		$	1,929		$	1,579		$	83	$	1,662
Other comprehensive income (loss), net of tax:
Cumulative translation adjustment	(183		)	(3		)	(186		)	126			3		129
Retirement Plan and other retiree benefit adjustments	57			—			57			(310		)	—		(310		)
Gains (losses) on cash flow hedges	(4		)	—			(4		)	(7		)	—		(7		)
Other	46			—			46			(21		)	—		(21		)
Total Other comprehensive income (loss), net of tax	$	(84	)	$	(3	)	$	(87	)	$	(212	)	$	3	$	(209	)
Comprehensive income	$	1,757		$	85		$	1,842		$	1,367		$	86	$	1,453

During the third quarter of 2010, the Company amended certain provisions of its defined benefit, defined contribution and retiree medical plans in the U.S. As a result, the Company was required to remeasure the benefit obligations and assets of each affected plan as of the amendment date, September 1, 2010. The impact from the remeasurement was a charge of $550 ($344 aftertax) to Other comprehensive income (loss), net, as reflected in the table above, primarily due to the 100 basis point reduction in the discount rate since December 31, 2009. The incremental impact to the Company’s net income due to the plan amendments for the remainder of 2010 was not significant.

7. Earnings Per Share

	Three Months Ended
	September 30, 2011					September 30, 2010
	Income		Shares (millions)	Per Share		Income			Shares (millions)	Per Share
Net income attributable to Colgate-Palmolive Company	$	643				$	619
Preferred dividends	—					(9		)
Basic EPS	643		486.7	$	1.32	610			486.0	$	1.26
Stock options and restricted stock			3.8						3.8
Convertible preference stock	—		—			9			19.7
Diluted EPS	$	643	490.5	$	1.31	$	619		509.5	$	1.21

For the three months ended September 30, 2011 and 2010, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 1,202,090 and 4,248,553, respectively.

8

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

	Nine Months Ended
	September 30, 2011					September 30, 2010
	Income		Shares (millions)	Per Share		Income			Shares (millions)	Per Share
Net income attributable to Colgate-Palmolive Company	$	1,841				$	1,579
Preferred dividends	—					(25		)
Basic EPS	1,841		489.9	$	3.76	1,554			489.9	$	3.17
Stock options and restricted stock			3.5						4.7
Convertible preference stock	—		—			25			20.1
Diluted EPS	$	1,841	493.4	$	3.73	$	1,579		514.7	$	3.07

For the nine months endedSeptember 30, 2011 and 2010, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 422,263 and 49,904, respectively.

As a result of recent rules issued by the Internal Revenue Service related to employer stock held in defined contribution plans, the Company issued a notice of redemption with respect to the 2,405,192 shares of preference stock outstanding on December 29, 2010.  At the direction of the Company’s ESOP trustee, the shares of preference stock were converted into 19,241,536 shares of common stock.

8. Retirement Plans and Other Retiree Benefits

Components of net periodic benefit cost for the three and nine months endedSeptember 30, 2011 and 2010 were as follows: 

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended September 30,
	2011			2010			2011			2010			2011			2010
Service cost	$	5		$	11		$	6		$	4		$	2		$	3
Interest cost	24			23			9			9			8			9
Annual ESOP allocation	—			—			—			—			—			(1		)
Expected return on plan assets	(27		)	(25		)	(7		)	(7		)	(1		)	(1		)
Amortization of transition and prior service costs (credits)	2			1			—			1			—			—
Amortization of actuarial loss	12			13			2			2			3			4
Net periodic benefit cost	$	16		$	23		$	10		$	9		$	12		$	14

9

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

	Pension Benefits												Other Retiree Benefits
	United States						International
	Nine Months Ended September 30,
	2011			2010			2011			2010			2011			2010
Service cost	$	18		$	36		$	16		$	13		$	8		$	10
Interest cost	75			71			28			26			29			30
Annual ESOP allocation	—			—			—			—			(1		)	(5		)
Expected return on plan assets	(83		)	(76		)	(21		)	(19		)	(2		)	(2		)
Amortization of transition and prior service costs (credits)	7			3			2			1			3			—
Amortization of actuarial loss	35			35			7			7			12			11
Net periodic benefit cost	$	52		$	69		$	32		$	28		$	49		$	44

For the nine months ended September 30, 2011 and 2010 the Company made voluntary contributions of $178 and $35, respectively, to its U.S. postretirement plans.

9. Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, environmental and tax matters. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

As a matter of course, the Company is regularly audited by the IRS and other tax authorities around the world in countries where it conducts business. In this regard, the IRS has completed its examination of the Company’s federal income tax returns through 2005. Estimated incremental tax payments related to potential disallowances for subsequent periods are not expected to be material.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $250 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more of these matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

10

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Brazilian Matters

In 2001, the Central Bank of Brazil sought to impose a substantial fine on the Company’s Brazilian subsidiary based on alleged foreign exchange violations in connection with the financing of the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (formerly American Home Products) (the Seller), as described in the Company’s Form 8-K dated January 10, 1995. The Company appealed the imposition of the fine to the Brazilian Monetary System Appeals Council (the Council), and on January 30, 2007, the Council decided the appeal in the Company’s favor, dismissing the fine entirely. However, certain tax and civil proceedings that began as a result of this Central Bank matter are still outstanding as described below.

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, at the current exchange rate, approximate $113. The Company has been disputing the disallowances by appealing the assessments within the internal revenue authority’s appellate process with the following results to date:

▪ In June 2005, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1996 through 1998. In March 2007, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1999 through 2001. The tax authorities appealed these decisions to the next administrative level.

▪ In August 2009, the First Taxpayers’ Council (the next and final administrative level of appeal) overruled the decisions of the First Board of Taxpayers, upholding the majority of the assessments, disallowing a portion of the assessments and remanding a portion of the assessments for further consideration by the First Board of Taxpayers.

The Company has filed a motion for reconsideration with the First Taxpayers’ Council and further appeals are available within the Brazilian federal courts. The Company intends to challenge these assessments vigorously. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel and other advisors, that the disallowances are without merit and that the Company should ultimately prevail on appeal, if necessary, in the Brazilian federal courts.

In 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company intends to challenge this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest and penalties of approximately $67, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company is disputing the assessment within the internal revenue authority’s administrative appeals process. In October 2007, the Second Board of Taxpayers, which has jurisdiction over these matters, ruled in favor of the internal revenue authority. In January 2008, the Company appealed this decision to the next administrative level. Although there can be no assurances, management believes, based on the advice of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should prevail on appeal either at the administrative level or, if necessary, in the Brazilian federal courts. The Company intends to challenge this assessment vigorously.

European Competition Matters

Since February 2006, the Company has learned that investigations relating to potential competition law violations involving the Company’s subsidiaries had been commenced by governmental authorities in a number of European countries and by the European Commission. The Company understands that many of these investigations also involve other consumer goods companies and/or retail customers. The status of the various pending matters is discussed below.

11

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Fines have been imposed on the Company in the following matters, although the Company is appealing these fines:

▪ In December 2009, the Swiss competition law authority imposed a fine of $5 on the Company’s GABA subsidiary for alleged violations of restrictions on parallel imports into Switzerland. The Company is appealing the fine in the Swiss courts.

▪ In January 2010, the Spanish competition law authority found that four suppliers of shower gel had entered into an agreement regarding product down-sizing, for which Colgate’s Spanish subsidiary was fined $3. The Company is appealing the fine in the Spanish courts.

▪ In December 2010, the Italian competition law authority found that 16 consumer goods companies, including the Company’s Italian subsidiary, exchanged competitively sensitive information in the cosmetics sector, for which the Company’s Italian subsidiary was fined $3. The Company is appealing the fine in the Italian courts.

Currently, formal claims of violations, or statements of objections, are pending against the Company as follows:

▪ The French competition authority alleges agreements on pricing and promotion of heavy duty detergents among four consumer goods companies, including the Company’s French subsidiary.

▪ The French competition authority alleges violations of competition law by three pet food producers, including the Company’s Hill’s France subsidiary, focusing on exclusivity arrangements and parallel trade restrictions.

▪ The German competition authority alleges that 17 branded goods companies, including the Company’s German subsidiary, exchanged sensitive information related to the German market.

The Company has responded to each of these formal claims of violations. Investigations are ongoing in Belgium, France and Greece, but no formal claims of violations have been filed in these jurisdictions except in France as noted above.

Since December 31, 2010, the following matters have been resolved:

▪ In April 2011, the investigation by the European Commission was resolved with no formal claims of violations or decisions made against the Company. To the Company’s knowledge, there are no other investigations by the European Commission relating to potential competition law violations involving the Company or its subsidiaries.

▪ In May 2011, the Dutch competition authority closed its investigation and no decision was made against the Company or its Dutch subsidiary.

The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The Company has undertaken a comprehensive review of its selling practices and related competition law compliance in Europe and elsewhere and, where the Company has identified a lack of compliance, it has undertaken remedial action. Competition and antitrust law investigations often continue for several years and can result in substantial fines for violations that are found. Such fines, depending on the gravity and duration of the infringement as well as the value of the sales involved, have amounted, in some cases, to hundreds of millions of dollars. While the Company cannot predict the final financial impact of these competition law issues as these matters may change, the Company evaluates developments in these matters quarterly and accrues liabilities as and when appropriate.

ERISA Matters

In October 2007, a putative class action claiming that certain aspects of the cash balance portion of the Colgate-Palmolive Company Employees’ Retirement Income Plan (the Plan) do not comply with the Employee Retirement Income Security Act was filed against the Plan and the Company in the United States District Court for the Southern District of New York. Specifically, Proesel, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al. alleges improper calculation of lump sum distributions, age discrimination and failure to satisfy minimum accrual requirements, thereby resulting in the underpayment of benefits to Plan participants. Two other putative class actions filed earlier in 2007, Abelman, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al., in the United States District

12

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Court for the Southern District of Ohio, and Caufield v. Colgate-Palmolive Company Employees’ Retirement Income Plan, in the United States District Court for the Southern District of Indiana, both alleging improper calculation of lump sum distributions and, in the case of Abelman, claims for failure to satisfy minimum accrual requirements, were transferred to the Southern District of New York and consolidated with Proesel into one action, In re Colgate-Palmolive ERISA Litigation. The complaint in the consolidated action alleges improper calculation of lump sum distributions and failure to satisfy minimum accrual requirements, but does not include a claim for age discrimination. The relief sought includes recalculation of benefits in unspecified amounts, pre- and post-judgment interest, injunctive relief and attorneys’ fees. This action has not been certified as a class action as yet. The parties are in discussions via non-binding mediation to determine whether the action can be settled. The Company and the Plan intend to contest this action vigorously should the parties be unable to reach a settlement.

10. Segment Information

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of the operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes. Corporate operations include stock-based compensation related to stock options and restricted stock awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company in order to measure the underlying performance of the business segments.  

Net sales and Operating profit by segment were as follows:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2011			2010			2011			2010
Net sales
Oral, Personal and Home Care
North America	$	776		$	753		$	2,238		$	2,274
Latin America	1,243			1,069			3,571			3,130
Europe/South Pacific	972			821			2,661			2,415
Greater Asia/Africa	855			779			2,484			2,239
Total Oral, Personal and Home Care	3,846			3,422			10,954			10,058
Pet Nutrition	537			521			1,608			1,528
Total Net sales	$	4,383		$	3,943		$	12,562		$	11,586
Operating profit
Oral, Personal and Home Care
North America	$	213		$	224		$	599		$	668
Latin America	364			332			1,050			975
Europe/South Pacific	196			197			551			572
Greater Asia/Africa	202			195			604			573
Total Oral, Personal and Home Care	975			948			2,804			2,788
Pet Nutrition	127			138			408			413
Corporate	(67		)	(128		)	(294		)	(617		)
Total Operating profit	$	1,035		$	958		$	2,918		$	2,584

13

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

For the three and nine months ended September 30, 2011, Corporate Operating profit includes a gain on the sale of the laundry detergent brands in Colombia of $207, costs of $168 associated with various business realignment and other cost-saving initiatives and costs of $7 related to the sale of land in Mexico. The various business realignment and other cost-saving initiatives include the integration of Sanex, the right-sizing of the Colombia business and the closing of an oral care facility in Mississauga, Canada and a Hill’s facility in Los Angeles, California. For further information regarding the sale of land in Mexico, refer to Note 3. In 2010, Corporate Operating profit includes the one-time charge of $271 related to the transition to hyperinflationary accounting in Venezuela as of January 1, 2010. For further information regarding Venezuela, refer to Note 12.

11. Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to credit losses in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely as it is the Company’s policy to contract only with diverse, highly rated counterparties.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, supplier agreements, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented.

The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). Foreign currency contracts consist of forward, option and swap contracts utilized to hedge a portion of the Company’s foreign currency purchases, assets and liabilities created in the normal course of business as well as the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in the Company’s operations. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.

14

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at September 30, 2011 and December 31, 2010:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		9/30/11		12/31/10			9/30/11		12/31/10
Interest rate swap contracts	Other current assets & Other assets	$	45	$	22	Other liabilities	$	—	$	7
Foreign currency contracts	Other current assets	8		10		Other accruals	8		10
Commodity contracts	Other current assets	—		4		Other accruals	3		—
Total designated		$	53	$	36		$	11	$	17
Derivatives not designated
Foreign currency contracts	Other assets	$	2	$	—	Other accruals	$	—	$	2
Total not designated		$	2	$	—		$	—	$	2
Total derivative instruments		$	55	$	36		$	11	$	19
Other financial instruments
Marketable securities	Other current assets	$	72	$	74
Available-for-sale securities	Other assets	233		228
Total other financial instruments		$	305	$	302

The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of September 30, 2011 and December 31, 2010. The estimated fair value of the Company’s long-term debt, including the current portion, as of September 30, 2011 and December 31, 2010, was $5,020 and $3,613, respectively, and the related carrying value was $4,689 and $3,376, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

Fair value hedges

The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting loss or gain on the hedged item are recognized in current earnings. The impact of foreign currency contracts is recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest expense, net.

During the second quarter of 2011, the Company issued $250 of six-year notes at a fixed rate of 2.625% and $250 of three-year notes at a fixed rate of 1.250% under the Company’s shelf registration statement. The Company simultaneously entered into interest rate swaps to effectively convert the fixed rate of the notes to a variable rate.

15

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Activity related to fair value hedges recorded during the three-month and nine-month periods ended September 30, 2011 and 2010 was as follows:

	2011									2010
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at September 30	$	619		$	1,288		$	1,907		$	1,080		$	600		$	1,680
Three-months ended September 30:
Gain (loss) on derivative	—			22			22			26			4			30
Gain (loss) on hedged items	—			(22		)	(22		)	(26		)	(4		)	(30		)
Nine-months ended September 30:
Gain (loss) on derivative	6			30			36			22			13			35
Gain (loss) on hedged items	(6		)	(30		)	(36		)	(22		)	(13		)	(35		)

Cash flow hedges

All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (OCI) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.

Activity related to cash flow hedges recorded during the three-month and nine-month periods ended September 30, 2011 and 2010 was as follows:

	2011									2010
	Foreign Currency Contracts			Commodity Contracts			Total			Foreign Currency Contracts			Commodity Contracts			Total
Notional Value at September 30	$	326		$	32		$	358		$	292		$	16		$	308
Three-months ended September 30:
Gain (loss) recognized in OCI	(2		)	(2		)	(4		)	(11		)	5			(6		)
Gain (loss) reclassified into Cost of sales	(5		)	1			(4		)	(3		)	—			(3		)
Nine-months ended September 30:
Gain (loss) recognized in OCI	(9		)	(2		)	(11		)	(10		)	2			(8		)
Gain (loss) reclassified into Cost of sales	(13		)	6			(7		)	—			(1		)	(1		)

The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is expected to be recognized in Cost of sales within the next twelve months.

Net investment hedges

The Company has designated certain foreign currency forward and option contracts and certain foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Currency translation adjustments within OCI, along with the offsetting gain or loss on the hedged items.

16

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Activity related to net investment hedges recorded during the three-month and nine-month periods ended September 30, 2011 and 2010 was as follows:

	2011									2010
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at September 30	$	32		$	348		$	380		$	76		$	279		$	355
Three-months ended September 30:
Gain (loss) on instruments	2			23			25			(10		)	(31		)	(41		)
Gain (loss) on hedged items	(2		)	(23		)	(25		)	10			31			41
Nine-months ended September 30:
Gain (loss) on instruments	(8		)	(10		)	(18		)	(6		)	3			(3		)
Gain (loss) on hedged items	8			10			18			6			(3		)	3

Derivatives Not Designated as Hedging Instruments

Derivatives not designated as hedging instruments for each period consist of a cross-currency swap that serves as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item are recognized in Other (income) expense, net for each period. The cross-currency swap outstanding at December 31, 2010 was settled during the second quarter of 2011, resulting in a realized loss of $6 which was offset by a corresponding gain on an underlying deposit. A new cross-currency swap with similar terms and an underlying foreign currency deposit was entered into during June 2011.

Activity related to these contracts during the three-month and nine-month periods ended September 30, 2011 and 2010 was as follows:

	2011			2010
	Cross-currency Swap			Cross-currency Swap
Notional Value at September 30	$	96		$	90
Three-months ended September 30:
Gain (loss) on instrument	2			(5		)
Gain (loss) on hedged item	(2		)	5
Nine-months ended September 30:
Gain (loss) on instrument	(2		)	1
Gain (loss) on hedged item	2			(1		)

Other Financial Instruments

Marketable securities consist of bank deposits with original maturities greater than 90 days (Level 1 valuation).

Available-for-sale securities consist of the fixed income investments discussed below.

In 2010, the Company invested in a portfolio of euro-denominated investment grade fixed income securities, including corporate bonds, with maturities generally ranging from one to three years. During the second quarter of 2011, the Company liquidated the investment portfolio as part of the cash management strategy to fund the acquisition of the Sanex business. The portfolio was considered a Level 1 investment as all of the securities had quoted prices on an active exchange with daily liquidity. At December 31, 2010, the portfolio’s fair value was $132 and was reported in Other assets in the Condensed Consolidated Balance Sheet.

17

COLGATE-PALMOLIVE COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Through its subsidiary in Venezuela, the Company has also invested in U.S. dollar-linked, devaluation-protected bonds issued by the Venezuelan government. As of December 31, 2010, these bonds were considered Level 3 as there was no trading activity in the market at the end of 2010 and their value was determined using unobservable inputs reflecting the Company’s own assumptions. As of September 30, 2011, these bonds are actively traded and, therefore, are considered Level 2 as their value is determined based upon observable market-based inputs or unobservable inputs that are corroborated by market data.

The following table presents a reconciliation of the Venezuelan investments at fair value for the nine months ended September 30:

	2011		2010
Beginning balance as of January 1	$	96	$	46
Unrealized gain (loss) on investment	60		(19		)
Purchases and sales during the period	77		23
Ending balance as of September 30	$	233	$	50

As a result of the Venezuelan government’s elimination of the two-tier exchange rate structure effective January 1, 2011, these bonds have revalued and the Company recorded an unrealized gain of $62 in the first quarter of 2011. For further information regarding Venezuela, refer to Note 12 below.

12. Venezuela

Effective January 1, 2010, Venezuela was designated as hyperinflationary and therefore the functional currency for the Company’s Venezuelan subsidiary (CP Venezuela) became the U.S. dollar. As a result, the impact of Venezuelan currency fluctuations is reported in income. The change in the reporting currency from the Venezuelan bolivar fuerte to the U.S. dollar resulted in a one-time charge of $271 recorded within Other (income) expense, net in the first quarter of 2010. This charge primarily represented the premium paid to acquire U.S. dollar-denominated cash ($150) and bonds ($152) at the parallel market rate, offset by $31 for U.S. dollar-denominated payables. Previously these items had been remeasured at the parallel market rate and then translated for financial reporting purposes at the official rate of 2.15.

On January 8, 2010, the Venezuelan government announced its decision to devalue its currency and implement a two-tier exchange rate structure. As a result, the official exchange rate changed from 2.15 to 2.60 for essential goods and 4.30 for non-essential goods. The devaluation resulted in a one-time pretax gain of $46 recorded in Other (income) expense and an aftertax gain of $59 in the first quarter of 2010 related to the remeasurement of the local balance sheet and lower taxes on accrued but unpaid remittances from Venezuela. In December 2010, the Venezuelan government announced that, effective January 1, 2011, the 2.60 exchange rate for essential goods would be abolished. As a result, CP Venezuela incurred an aftertax loss of $36 in the fourth quarter of 2010 related to the remeasurement of certain local balance sheet items for which the 2.60 exchange rate would no longer be received. This loss was offset by lower taxes on accrued but unpaid remittances.

The Company remeasures the financial statements of CP Venezuela at the rate at which it expects to remit future dividends, which currently is 4.30. As a result of the devaluations of the Venezuelan bolivar fuerte, the local currency operations of CP Venezuela now translate into fewer U.S. dollars.

For the nine months ended September 30, 2011, CP Venezuela represented 5% of the Company’s consolidated Net sales. At September 30, 2011, CP Venezuela’s bolivar fuerte-denominated monetary net asset position was approximately $277 which does not include $233 of devaluation-protected bonds issued by the Venezuelan government, as these bonds provide protection against devaluations by adjusting the amount of bolivares fuertes received at maturity for any devaluation subsequent to issuance. As described in Note 11, these bonds are considered a Level 2 investment.

18

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Executive Overview and Outlook

Colgate-Palmolive Company seeks to deliver strong, consistent business results and superior shareholder returns by providing consumers on a global basis with products that make their lives healthier and more enjoyable.

To this end, the Company is tightly focused on two product segments: Oral, Personal and Home Care; and Pet Nutrition. Within these segments, the Company follows a closely defined business strategy to develop and increase market leadership positions in key product categories. These product categories are prioritized based on their capacity to maximize the use of the organization’s core competencies and strong global equities and to deliver sustainable long-term growth.

Operationally, the Company is organized along geographic lines with management teams having responsibility for the business and financial results in each region. The Company competes in more than 200 countries and territories worldwide with established businesses in all regions contributing to the Company’s sales and profitability. This geographic diversity and balance help to reduce the Company’s exposure to business and other risks in any one country or part of the world.

The Oral, Personal and Home Care segment is operated through four reportable operating segments: North America, Latin America, Europe/South Pacific and Greater Asia/Africa, all of which sell to a variety of retail and wholesale customers and distributors. The Company, through Hill’s Pet Nutrition, also competes on a worldwide basis in the pet nutrition market, selling its products principally through specialty pet retailers and the veterinary profession.

On an ongoing basis, management focuses on a variety of key indicators to monitor business health and performance. These indicators include market share, sales (including volume, pricing and foreign exchange components), organic sales growth (Net sales growth excluding the impact of foreign exchange, acquisitions and divestments), gross profit margin, operating profit, net income and earnings per share, as well as measures used to optimize the management of working capital, capital expenditures, cash flow and return on capital. The monitoring of these indicators, and the Company’s corporate governance practices (including the Company’s Code of Conduct), help to maintain business health and strong internal controls.

To achieve its business and financial objectives, the Company focuses the organization on initiatives to drive and fund growth. The Company seeks to capture significant opportunities for growth by identifying and meeting consumer needs within its core categories, through its focus on innovation and the deployment of valuable consumer and shopper insights in the development of successful new products regionally, which are then rolled out on a global basis. To enhance these efforts, the Company has developed key initiatives to build strong relationships with consumers, dental and veterinary professionals and retail customers. Growth opportunities are greater in those areas of the world in which economic development and rising consumer incomes expand the size and number of markets for the Company’s products.

The investments needed to support this growth are developed through continuous, Company-wide initiatives to lower costs and  increase effective asset utilization through which the Company seeks to become even more effective and efficient throughout its businesses, which are referred to as the Company’s funding-the-growth initiatives. The Company also continues to prioritize its investments toward its higher margin businesses, specifically Oral Care, Personal Care and Pet Nutrition.

On June 20, 2011, the Company, Colgate-Palmolive Europe Sàrl, Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever”) finalized the Company’s acquisition from Unilever of the Sanex personal care business in accordance with a Business and Share Sale and Purchase Agreement for an aggregate purchase price of €672 ($960), subject to certain post-closing purchase price adjustments. The acquisition was financed with available cash, proceeds from the sale of the Company’s Euro-denominated investment portfolio and the issuance of commercial paper.

On July 29, 2011, in connection with the Sanex acquisition, Colgate sold its laundry detergent brands in Colombia to Unilever for $215 resulting in a pretax gain of $207 ($135 aftertax gain) in the third quarter of 2011. This gain was offset by pretax costs of $168 ($128 aftertax costs) associated with various business realignment and other cost-saving initiatives and pretax costs of $7 ($5 aftertax costs) related to the sale of land in Mexico, as discussed further below.

19

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

The various business realignment and other cost-saving initiatives include the integration of Sanex, the right-sizing of the Colombia business and the closing of an oral care facility in Mississauga, Canada and a Hill’s facility in Los Angeles, California. The Company expects to incur aftertax costs of $10-$12 in the fourth quarter of 2011 and $10-$15 in 2012 related to these initiatives.

On September 13, 2011, the Company's Mexican subsidiary entered into an agreement to sell the Mexico City site on which its commercial operations, technology center and soap production facility are located. The sale price is payable in three installments, with the final installment due upon the transfer of the property, which is expected to occur in 2014. The Company intends to re-invest these payments to relocate its soap production to a new state-of-the-art facility to be constructed at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. As a result, over the next three years, the Company expects to make capital improvements and incur costs to exit the site. These exit costs will primarily be related to staff leaving indemnities, accelerated depreciation and demolition.

With over 75% of its Net sales generated outside of the United States, the Company is exposed to changes in economic conditions and foreign currency exchange rates, as well as political uncertainty in some countries, all of which could impact future operating results. For example, as discussed in detail below, the operating environment in Venezuela is challenging, with economic uncertainty fueled by currency devaluations and high inflation and governmental restrictions in the form of import authorization controls, currency exchange controls, price controls and periodic expropriation of property or other resources in non-consumer product industries.

In particular, as a result of the devaluations of the Venezuelan bolivar fuerte, described more fully in Note 12 “Venezuela” to the Condensed Consolidated Financial Statements, the local currency operations of the Company’s Venezuelan subsidiary (CP Venezuela) now translate into fewer U.S. dollars. The Company has taken, and continues to take, actions to mitigate the impact of both devaluations on its operations.

Additionally, the Venezuelan government continues to impose import authorization controls and currency exchange and payment controls. During 2010, a new currency market was established and the government closed the free-floating parallel market. Under existing regulations, CP Venezuela is not permitted to access the new currency market, but continues to have limited access to U.S. dollars at the official rate, and currently only for imported goods. As a result, CP Venezuela funds its requirements for imported goods through a combination of U.S. dollars obtained from the government at the official rate, intercompany borrowings and existing U.S. dollar cash balances, which were obtained previously through parallel market transactions and through the prior liquidation of its U.S. dollar-denominated bond portfolio.

The Company’s business in Venezuela and the Company’s ability to repatriate its earnings continue to be negatively affected by these difficult conditions and would be further negatively affected by additional devaluations or the imposition of additional import authorization controls and currency exchange controls. For the nine months ended September 30, 2011, CP Venezuela represented 5% of the Company’s consolidated Net sales. At September 30, 2011, CP Venezuela’s local currency monetary net asset position was approximately $277.

Looking forward, we expect global macroeconomic and market conditions to remain highly challenging. While the global marketplace in which we operate has always been highly competitive, the Company continues to experience heightened competitive activity in certain markets from other large multinational companies, some of which may have greater resources than we do. Such activities have included more aggressive product claims and marketing challenges, as well as increased promotional spending. Additionally, we continue to experience sharp rises in commodity costs. While the Company has taken, and will continue to take, measures to address the heightened competitive activity and increased commodity costs, should these conditions persist, they could adversely affect the Company’s future results.

The Company believes it is well prepared to meet the challenges ahead due to its strong financial condition, experience operating in challenging environments and continued focus on the Company’s recently updated strategic initiatives: engaging to build our brands; innovation for growth; effectiveness and efficiency in everything; and leading to win. This focus, together with the strength of the Company’s global brand names and its broad international presence in both mature and emerging markets, should position the Company well to increase shareholder value over the long-term.

20

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Results of Operations

Three Months

Worldwide Net sales were $4,383 in the third quarter of 2011, up 11.0% from the third quarter of 2010, driven by volume growth of 4.5%, net selling price increases of 2.0% and a positive foreign exchange impact of 4.5%. Excluding the impact of the divestment of non-core laundry detergent brands in Colombia, volume increased 5.0%. The Sanex business contributed 2.0% to worldwide Net sales and volume growth in the third quarter of 2011. Organic sales (Net sales excluding foreign exchange, acquisitions and divestments) increased 5.0%, on organic volume growth of 3.0% in the third quarter of 2011. Organic volume growth excludes the impact of acquisitions and divestments.

Net sales in the Oral, Personal and Home Care segment were $3,846 in the third quarter of 2011, up 12.5% from the third quarter of 2010, driven by volume growth of 6.0%, net selling price increases of 2.0% and a positive foreign exchange impact of 4.5%. Excluding the impact of the divestment of non-core detergent brands in Colombia, volume increased 6.5%. The Sanex business contributed 2.5% to sales and volume growth in the third quarter of 2011. Organic sales in the Oral, Personal and Home Care segment increased 6.0% on organic volume growth of 4.0% in the third quarter of 2011.

Worldwide Gross profit margin decreased to 56.2% in the third quarter of 2011 from 59.4% in the third quarter of 2010. Excluding the impact of costs associated with various business realignment and other cost-saving initiatives of 60 bps, gross profit margin was 56.8% in the third quarter of 2011. The decrease in the third quarter of 2011 was primarily due to higher raw and packaging material costs driven by global commodity cost increases (530 bps), partially offset by cost savings from the Company’s funding-the-growth initiatives (210 bps) and by higher pricing (80 bps).

Selling, general and administrative expenses as a percentage of Net sales decreased to 34.0% in the third quarter of 2011 from 35.3% in the third quarter of 2010, due to lower advertising as a percentage of Net sales and due to lower overhead costs. In the third quarter of 2011, advertising increased 4.2% to $450 as compared with $432 in the third quarter of 2010, but decreased as a percentage of Net sales from 11.0% in the third quarter of 2010 to 10.3% in the third quarter of 2011.

Other (income) expense, net was ($62) in the third quarter of 2011 as compared with ($5) in the third quarter of 2010. In the third quarter of 2011, Other (income) expense, net includes the gain on the sale of the laundry detergent brands in Colombia of $207, costs of $135 associated with various business realignment and other cost-saving initiatives, transaction costs of $2 related to the Sanex acquisition and costs of $7 related to the sale of land in Mexico.

Operating profit increased 8% to $1,035 in the third quarter of 2011 from $958 in 2010. Excluding the non-recurring items incurred in 2011 as described above, Operating profit increased 5% to $1,003 in the third quarter of 2011 as compared to the same period last year.

North America

	Three Months Ended September 30,						Change
	2011			2010
Net sales	$	776		$	753		3.0		%
Operating profit	$	213		$	224		(5	)	%
% of Net sales	27.4		%	29.7		%	(230	)	bps

Net sales in North America increased 3.0% in the third quarter of 2011 to $776, as volume growth of 5.0% and a positive foreign exchange impact of 0.5% were partially offset by net selling price decreases of 2.5%. Organic sales in North America increased 2.5% in the third quarter of 2011. Products contributing to volume gains in oral care included Colgate Optic White and Colgate Sensitive Pro-Relief toothpastes and the relaunch of Colgate Total toothpaste and Colgate 360° Optic White, Colgate 360° Sensitive Pro-Relief and Colgate 360° Surround manual toothbrushes. Successful new products in other categories contributing to volume growth included Softsoap brand Pomegranate and Mango Infusions and Softsoap brand Coconut Scrub bar soaps and Palmolive Soft Touch with Vitamin E dish liquid.

21

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Operating profit in North America decreased 5% in the third quarter of 2011 to $213, or 27.4% of Net sales. This decrease in Operating profit as a percentage of Net sales was driven by a decrease in Gross profit as a percentage of Net sales which was partially offset by a decrease in Selling, general and administrative expenses as a percentage of Net sales. The decrease in Gross profit as a percentage of Net sales was due to lower pricing due to increased promotional investments and higher raw and packaging material costs reflecting global commodity cost increases, which were partially offset by cost savings from the Company’s funding-the-growth initiatives. The decrease in Selling, general and administrative expenses as a percentage of Net sales reflects lower advertising expenses as a percentage of Net sales.

Latin America

	Three Months Ended September 30,							Change
	2011				2010
Net sales	$	1,243		1,069	$	1,069		16.0		%
Operating profit	$	364			$	332		10		%
% of Net sales	29.3		%		31.1		%	(180	)	bps

Net sales in Latin America increased 16.0% in the third quarter of 2011 to $1,243, driven by volume growth of 4.0%, net selling price increases of 9.0% and a positive foreign exchange impact of 3.0%. Organic sales in Latin America increased 15.5% and, excluding the impact of the divested detergent brands in Colombia, volume increased 6.5% in the third quarter of 2011. The divestment had an impact of 2.5% on sales and volume growth in Latin America. Volume gains were led by Brazil and Mexico. Products contributing to the growth in oral care included Colgate Sensitive Pro-Relief, Colgate Sensitive Pro-Relief Whitening, Colgate Total and Colgate Triple Action toothpastes, Colgate 360° Surround, Colgate Twister, Colgate Triple Action and Colgate Zig Zag manual toothbrushes and Colgate Plax Whitening Tartar Control and Colgate Plax Complete Care mouthwashes. Products contributing to growth in other categories included Palmolive Naturals Relaxing Softness Cream and Lavender and Protex Advanced Clean bar soaps, Lady Speed Stick Stainguard and Speed Stick Sensitive Power deodorants and Suavitel Dusk fabric conditioner.

While Operating profit in Latin America increased 10% in the third quarter of 2011 to $364, driven by strong sales growth, it decreased as a percentage of Net sales to 29.3%. This decrease in Operating profit as a percentage of Net sales was due to a decrease in Gross profit as a percentage of Net sales partially offset by a decrease in Selling, general and administrative expenses as a percentage of Net sales. The decrease in Gross profit as a percentage of Net sales was driven by higher raw and packaging material costs reflecting global commodity cost increases, which were partially offset by higher pricing and cost savings from the Company’s funding-the-growth initiatives. The decrease in Selling, general and administrative expenses as a percentage of Net sales was primarily due to a reduction in overhead expenses, partially offset by higher advertising investments supporting volume growth.

Europe/South Pacific

	Three Months Ended September 30,						Change
	2011			2010
Net sales	$	972		$	821		18.5		%
Operating profit	$	196		$	197		(1	)	%
% of Net sales	20.2		%	24.0		%	(380	)	bps

Net sales in Europe/South Pacific increased 18.5% in the third quarter of 2011 to $972, as volume growth of 10.0% and the positive impact of foreign exchange of 11.0% were partially offset by net selling price decreases of 2.5%. The Sanex business contributed 9.0% to Europe/South Pacific sales and volume growth in the third quarter of 2011. Organic sales in Europe/South Pacific decreased by 1.5% as organic volume growth of 1.0% was more than offset by net selling price decreases of 2.5% in the third quarter of 2011. Volume gains were led by the United Kingdom, Spain and France. Successful products in oral care included Colgate Sensitive Pro-Relief Whitening, elmex Sensitive Professional, Colgate Max White One and Colgate Max Fresh Night toothpastes, Colgate 360° Surround toothbrush and Colgate Max White One Sonic Power battery powered toothbrush. Successful products in other categories included Sanex Zero% and Sanex Dermo

22

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Repair shower gels and Palmolive "Authentic" shower gels and liquid hand soaps containing Mediterranean inspired fragrances and ingredients and the relaunch of Palmolive Aromatherapy and Thermal Spa shower gels with multi-sensory features.

Operating profit in Europe/South Pacific decreased 1% in the third quarter of 2011 to $196, or 20.2% of Net sales. This decrease in Operating profit as a percentage of Net sales was due to a decrease in Gross profit as a percentage of Net sales and an increase in Selling, general and administrative expenses as a percentage of Net sales. The decrease in Gross profit as a percentage of Net sales was due to higher raw and packaging material costs reflecting global commodity cost increases, which were partially offset by cost savings from the Company’s funding-the-growth initiatives. Selling, general and administrative expenses as a percentage of Net sales increased due to increased overhead expenses.

Greater Asia/Africa

	Three Months Ended September 30,						Change
	2011			2010
Net sales	$	855		$	779		9.5		%
Operating profit	$	202		$	195		4		%
% of Net sales	23.6		%	25.0		%	(140	)	bps

Net sales in Greater Asia/Africa increased 9.5% in the third quarter of 2011 to $855, driven by volume growth of 4.0%, net selling price increases of 2.0% and a 3.5% positive impact of foreign exchange. The Sanex business contributed 0.5% to Greater Asia/Africa sales and volume growth in the third quarter of 2011. Organic sales in Greater Asia/Africa grew 5.5% on organic volume growth of 3.5% in the third quarter of 2011. Volume gains were led by the Greater China region, India, Russia and Malaysia and were partially offset by volume declines in Turkey and Ukraine. Successful products driving the oral care growth included Colgate Sensitive Pro-Relief Whitening, Colgate Sensitive Pro-Relief Multi-Protection and Colgate Max White One toothpastes, the relaunch of Colgate Total toothpaste, Colgate 360° Surround and Colgate Max White One manual toothbrushes and Colgate Plax Fresh Tea mouthwash. Successful products contributing to growth in other categories included Palmolive Pomegranate and Mango Infusions liquid hand soap, Palmolive Naturals Black Orchid bar soap, shower gel and liquid hand soap and Protex Pro Plus bar soap.

While Operating profit in Greater Asia/Africa increased 4% in the third quarter of 2011 to $202 driven by strong sales growth, it decreased as a percentage of Net sales to 23.6%. This decrease in Operating profit as a percentage of Net sales was due to a decrease in Gross profit as a percentage to Net sales which was partially offset by a decrease in Selling, general and administrative expenses as a percentage of Net sales. The decrease in Gross profit as a percentage of Net sales was due to higher raw and packaging material costs reflecting global commodity cost increases, partially offset by higher pricing and cost savings from the Company’s funding-the-growth initiatives. Selling, general and administrative expenses as a percentage of Net sales decreased due to lower advertising expenses.

Pet Nutrition

	Three Months Ended September 30,						Change
	2011			2010
Net sales	$	537		$	521		3.0		%
Operating profit	$	127		$	138		(8	)	%
% of Net sales	23.6		%	26.5		%	(290	)	bps

Net sales for Hill’s Pet Nutrition increased 3.0% in the third quarter of 2011 to $537, as net selling price increases of 3.0%, and a positive foreign exchange impact of 4.0% were partially offset by volume decline of 4.0%. Organic sales in Hill’s Pet Nutrition decreased 1.0% in the third quarter of 2011. Volume decreases were driven by Russia and the United States. Successful new products within the U.S. included Science Diet Ideal Balance Canine, which combines natural ingredients with the power of advanced nutrition in one balanced package, Science Diet Savory Stew Canine, Science Diet Age

23

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Defying Feline (11 years plus) and the relaunch of Prescription Diet c/d Multicare Feline Bladder Health with evidence of improved efficacy and taste. Successful new products contributing to international sales included Science Diet Senior Advanced (15 years plus) Canine and Feline, reformulated Prescription Diet r/d Canine and Feline, the relaunch of Prescription Diet c/d Multicare Feline Bladder Health with evidence of improved efficacy and taste and the relaunch of Prescription Diet j/d Canine and Feline with upgraded ingredients.

Operating profit in Hill’s Pet Nutrition decreased 8% in the third quarter of 2011 to $127 or 23.6% of Net sales. This decrease in Operating profit as a percentage of Net sales was due to a decrease in Gross profit as a percentage of Net sales and an increase in Selling, general and administrative expenses as a percentage of Net sales. The decrease in Gross profit as a percentage of Net sales was due to higher raw and packaging material costs reflecting global commodity cost increases, and increased manufacturing overhead expenses due to increased investments in capacity, partially offset by cost savings from the Company’s funding-the-growth initiatives and higher pricing. Selling, general and administrative expenses increased as a percentage of Net sales due to increased logistics and overhead expenses.

Corporate

	Three Months Ended September 30,						Change
	2011			2010
Operating profit	$	(67	)	$	(128	)	(48	)	%

Operating profit (loss) related to Corporate was ($67) in the third quarter of 2011 as compared to ($128) in the third quarter of 2010. In the third quarter of 2011, Corporate Operating profit includes the gain on the sale of the laundry detergent brands in Colombia of $207, costs of $168 associated with various business realignment and other cost-saving initiatives, transaction costs of $2 related to the Sanex acquisition and costs of $7 related to the sale of land in Mexico.

Interest expense, net decreased to $10 for the three months ended September 30, 2011 as compared with $13 in the comparable period of 2010, due to an increase in interest income.

Net income attributable to Colgate-Palmolive Company for the third quarter of 2011 increased to $643 from $619 in the comparable 2010 period, and earnings per common share on a diluted basis increased to $1.31 per share from $1.21 per share in the comparable 2010 period. Net income attributable to Colgate-Palmolive Company for the third quarter of 2011 included an aftertax gain on the sale of the laundry detergent brands in Colombia of $135 ($0.27 per diluted share), which was offset by aftertax costs of $128 ($0.26 per diluted share) associated with various business realignment and other cost-saving initiatives and aftertax costs of $5 ($0.01 per diluted share) related to the sale of land in Mexico.

24

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Nine Months

Net sales and Operating profit by segment were as follows:

	Nine Months Ended September 30,
	2011			2010
Net sales
Oral, Personal and Home Care
North America	$	2,238		$	2,274
Latin America	3,571			3,130
Europe/South Pacific	2,661			2,415
Greater Asia/Africa	2,484			2,239
Total Oral, Personal and Home Care	10,954			10,058
Pet Nutrition	1,608			1,528
Total Net sales	$	12,562		$	11,586
Operating profit
Oral, Personal and Home Care
North America	$	599		$	668
Latin America	1,050			975
Europe/South Pacific	551			572
Greater Asia/Africa	604			573
Total Oral, Personal and Home Care	2,804			2,788
Pet Nutrition	408			413
Corporate	(294		)	(617		)
Total Operating profit	$	2,918		$	2,584

Worldwide Net sales were $12,562 in the first nine months of 2011, up 8.5% from the first nine months of 2010, driven by volume growth of 3.5%, net selling price increases of 0.5% and a positive foreign exchange impact of 4.5%. Organic sales increased 3.5% in the first nine months of 2011 on organic volume growth of 3.0%. The Sanex business contributed 0.5% to worldwide Net sales and volume growth in the first nine months of 2011.

Net sales in the Oral, Personal and Home Care segment were $10,954 in the first nine months of 2011, up 9.0% from 2010, driven by volume growth of 3.5%, a positive foreign exchange impact of 5.0% and net selling price increases of 0.5%. Organic sales increased 3.5%, on organic volume growth of 3.0% in the first nine months of 2011. Excluding the impact of the divestment of non-core detergent brands in Colombia of 0.5%, volume increased 4.0%. The Sanex business contributed 1.0% to Oral, Personal and Home Care segment sales and volume growth in the first nine months of 2011.

Within this segment, North America sales decreased 1.5% as net selling price decreases of 3.5% were partially offset by volume growth of 1.5% and a positive impact of foreign exchange of 0.5%. Organic sales in North America decreased 2.0%. Latin America sales increased 14.0%, driven by volume growth of 3.0%, net selling price increases of 6.5% and a positive impact of foreign exchange of 4.5%. Organic sales in Latin America increased 10.5% and, excluding the impact of the divestment of non-core detergent brands in Colombia, volume increased 4.0%. Europe/South Pacific sales increased 10.0% on volume growth of 4.0% and a positive impact of foreign exchange of 8.5%, which were partially offset by net selling price decreases of 2.5%. Organic sales in Europe/South Pacific decreased 1.5%. The Sanex business contributed 3.0% to Europe/South Pacific sales and volume growth. Greater Asia/Africa sales increased 11.0% on volume growth of 6.5%, net selling price increases of 0.5% and a positive impact of foreign exchange of 4.0%. Organic sales in Greater Asia/Africa increased 6.5%. The Sanex business contributed 0.5% to Greater Asia/Africa sales and volume growth.

25

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Net sales for the Hill’s Pet Nutrition segment increased 5.5% in the first nine months of 2011 to $1,608, driven by volume growth of 0.5%, net selling price increases of 1.0% and a positive foreign exchange impact of 4.0%. Organic sales increased 1.5% in the first nine months of 2011.

In the first nine months of 2011, Operating profit (loss) related to Corporate decreased to ($294) from ($617) in the comparable period of 2010. In the first nine months of 2011, Corporate Operating profit (loss) includes the gain on the sale of the laundry detergent brands in Colombia of $207, costs of $168 associated with various business realignment and other cost-saving initiatives, transaction costs of $12 related to the Sanex acquisition and costs of $7 related to the sale of land in Mexico. In the first nine months of 2010, Operating profit (loss) included a one-time charge of $271 related to the transition to hyperinflationary accounting in Venezuela as of January 1, 2010. 

Worldwide Gross profit margin decreased to 57.3% in the first nine months of 2011 from 59.2% in the first nine months of 2010. Excluding the impact of costs associated with various business realignment and other cost-saving initiatives of 20 bps, gross profit margin was 57.5% in the third quarter of 2011. The decrease was primarily due to higher raw and packaging material costs driven by global commodity cost increases (350 bps), partially offset by cost savings from the Company’s funding-the-growth initiatives (160 bps) and higher pricing (20 bps).

Selling, general and administrative expenses as a percentage of Net sales decreased to 34.3% in the first nine months of 2011 from 34.9% in the first nine months of 2010 primarily due to further reduction of overhead expenses and lower advertising as a percentage of Net sales. In the first nine months of 2011, advertising increased 4.5% to $1,306 as compared with $1,250 in the first nine months of 2010.

Other (income) expense, net was ($35) in the first nine months of 2011 as compared to $232 in the first nine months of 2010. In the first nine months of 2011, Other (income) expense, net includes the gain on the sale of the laundry detergent brands in Colombia of $207, costs of $135 associated with various business realignment and other cost-saving initiatives, transaction costs of $12 related to the Sanex acquisition and costs of $7 related to the sale of land in Mexico. Other (income) expense, net for the first nine months of 2010 included a one-time charge of $271 in Corporate related to the transition to hyperinflationary accounting in Venezuela as of January 1, 2010, partially offset by a one-time pretax gain of $46 recorded in Latin America related to the remeasurement of the CP Venezuela balance sheet as a result of the devaluation on January 8, 2010.

Operating profit increased 13% to $2,918 in the first nine months of 2011 from $2,584 in the first nine months of 2010. Excluding the non-recurring items in 2011 and 2010 described above, Operating profit increased 1% in the first nine months of 2011 as compared to the same period last year.

Interest expense, net decreased to $37 for the nine months ended September 30, 2011 from $43 in the comparable period of 2010, due to an increase in interest income.

The quarterly provision for income taxes is determined based on the Company’s estimated full year effective tax rate adjusted by the amount of tax attributable to infrequent and unusual items that are separately recognized on a discrete basis in the income tax provision in the quarter in which they occur. The Company’s current estimate of its full year effective income tax rate before discrete period items is 32.3%, which is consistent with the estimate of 32.5% in the second quarter of 2011 and 32.2% in the year ago period.

The effective tax rate for the third quarter of 2011 was 34.0% and 33.0% for the first nine months of 2011, as the rate in both periods was impacted by the gain on the sale of the laundry detergent brands in Colombia, the costs associated with various business realignment and other cost-saving initiatives and the costs related to the sale of land in Mexico, which were recorded in the third quarter of 2011. The third quarter rate was further impacted by the change in the current estimate of the annual effective tax rate noted above.

The effective tax rate for the first nine months of 2010 was 34.6%, as the rate was impacted by the one-time charge of $271 related to the transition to hyperinflationary accounting in Venezuela, as well as the one-time $59 gain from the remeasurement of the CP Venezuela balance sheet and lower taxes on accrued but unpaid remittances as a result of the devaluation also recorded in the first quarter of 2010.

26

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Net income attributable to Colgate-Palmolive Company in the first nine months of 2011 increased to $1,841 from $1,579 in the comparable 2010 period, and earnings per common share on a diluted basis increased to $3.73 per share from $3.07 per share in the comparable 2010 period. Net income attributable to Colgate-Palmolive Company for the first nine months of 2011 included an aftertax gain on the sale of the laundry detergent brands in Colombia of $135 ($0.27 per diluted share), which was offset by aftertax costs of $128 ($0.26 per diluted share) associated with various business realignment and other cost-saving initiatives and aftertax cost of $5 ($0.01 per diluted share) related to the sale of land in Mexico. Net income attributable to Colgate-Palmolive Company for the first nine months of 2010 included a one-time charge of $271 related to the transition to hyperinflationary accounting in Venezuela ($0.52 per diluted share). Excluding the items described above, Net income attributable to Colgate-Palmolive Company for the first nine months of 2011 decreased 1% and earnings per common share on a diluted basis increased 4%.

Liquidity and Capital Resources

Net cash provided by operations decreased 8% to $2,057 in the first nine months of 2011, compared with $2,243 in the comparable period of 2010. The decrease in the first nine months of 2011 was primarily due to an increase in voluntary benefit plan contributions.

The Company defines working capital as the difference between current assets (excluding cash and cash equivalents and marketable securities, the latter of which is reported in Other current assets) and current liabilities (excluding short-term debt). Overall, the Company’s working capital decreased to 0.6% of Net sales in the first nine months of 2011 as compared with 1.7% in the first nine months of 2010. The decrease in working capital as a percentage of Net sales in the first nine months of 2011 versus the comparable period of 2010 was due primarily to lower levels of accounts receivable and inventory resulting from ongoing efforts to improve cash cycle time.

Investing activities used $998 in the first nine months of 2011, compared with $438 in the comparable period of 2010. The increase was primarily due to the purchase of the Sanex business for $960 which was funded with available cash, including the proceeds from the sale of the Company's Euro-denominated investment portfolio, and the issuance of commercial paper, partially offset by the sale of the Company's laundry detergent brands in Colombia for $215 ($135 net of tax gain). Additionally, in the third quarter of 2011, the Company's Mexican subsidiary entered into an agreement to sell the Mexico City site on which its commercial operations, technology center and soap production facility are located. The sale price is payable in three installments, with the final installment due upon the transfer of the property, which is expected to occur in 2014. During the third quarter of 2011 the Company received the first installment of $24 upon signing the agreement. Capital spending also increased in the first nine months of 2011 to $324 from $318 in the comparable period of 2010 and continues to focus primarily on projects that yield high aftertax returns. Overall capital expenditures for 2011 are expected to be at an annual rate of approximately 3.5% of Net sales.

Financing activities used $566 of cash during the first nine months of 2011 compared with $1,745 in the comparable period of 2010. This difference was primarily due to higher net proceeds from the issuance of debt.

Long-term debt, including the current portion, increased to $4,689 as of September 30, 2011 as compared to $3,376 as of December 31, 2010 and total debt increased to $4,756 as of September 30, 2011 as compared to $3,424 as of December 31, 2010. During the second quarter of 2011, the Company issued $250 of six-year notes at a fixed rate of 2.625% and $250 of three-year notes at a fixed rate of 1.250% under the Company’s shelf registration statement. Proceeds from the debt issuances were used to reduce commercial paper borrowings.

Commercial paper outstanding was $986 and $575 as of September 30, 2011 and 2010, respectively. The average daily balances outstanding for commercial paper in the first nine months of 2011 and 2010 were $1,530 and $1,146, respectively. The maximum daily balance outstanding for commercial paper in the first nine months of 2011 and 2010 was $1,897 and $1,628, respectively. The Company regularly classifies commercial paper and certain current maturities of notes payable as long-term debt as it has the intent and ability to refinance such obligations on a long-term basis, including, if necessary, by utilizing its lines of credit that expire in 2012.

Certain of the facilities with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote.

27

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

In the first nine months of 2011, the Company increased the annualized common stock dividend by 12% to $2.27 per share effective in the second quarter of 2011. On September 8, 2011, the Company’s Board of Directors (the Board) authorized a share repurchase program that authorizes the repurchase of up to 50 million shares of the Company’s common stock.

For additional information regarding liquidity and capital resources, please refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2010.

Non-GAAP Financial Measures

This quarterly report on Form 10-Q discusses organic sales growth (Net sales growth excluding the impact of foreign exchange, acquisitions and divestments) (non-GAAP). Management believes this measure provides investors with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange, as well as the impact of acquisitions and divestments. A reconciliation of organic sales growth to Net sales growth for the three and nine months ended September 30, 2011 is provided below.

Worldwide Gross profit margin, Operating profit, Net income attributable to Colgate-Palmolive Company and earnings per share on a diluted basis are discussed in this quarterly report on Form 10-Q both on a GAAP basis and excluding the impacts of the gain on the sale of the laundry detergent brands in Colombia, costs associated with various business realignment and other cost-saving initiatives, costs related to the sale of land in Mexico and the one-time charge related to the transition to hyperinflationary accounting in Venezuela (non-GAAP). Management believes these measures provide investors with useful supplemental information regarding the performance of the Company’s on-going operations. A reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures for the three and nine months ended September 30, 2011 and 2010 is presented below.

The Company uses the above financial measures internally in its budgeting process and as a factor in determining compensation. While the Company believes that these non-GAAP financial measures are useful in evaluating the Company’s business, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.

The following table provides a quantitative reconciliation of organic sales growth to Net sales growth for the three months ended September 30, 2011.

Three months ended September 30, 2011	Organic Sales Growth (Non-GAAP)	Foreign Exchange Impact	Acquisitions and Divestments Impact	Net Sales Growth (GAAP)
Oral, Personal and Home Care
North America	2.5%	0.5%	0.0%	3.0%
Latin America	15.5%	3.0%	(2.5)%	16.0%
Europe/South Pacific	(1.5)%	11.0%	9.0%	18.5%
Greater Asia/Africa	5.5%	3.5%	0.5%	9.5%
Total Oral, Personal and Home Care	6.0%	4.5%	2.0%	12.5%
Pet Nutrition	(1.0)%	4.0%	0.0%	3.0%
Total Company	5.0%	4.5%	1.5%	11.0%

28

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

The following table provides a quantitative reconciliation of organic sales growth to Net sales growth for the nine months ended September 30, 2011.

Nine months ended September 30, 2011	Organic Sales Growth (Non-GAAP)	Foreign Exchange Impact	Acquisitions and Divestments Impact	Net Sales Growth (GAAP)
Oral, Personal and Home Care
North America	(2.0)%	0.5%	0.0%	(1.5)%
Latin America	10.5%	4.5%	(1.0)%	14.0%
Europe/South Pacific	(1.5)%	8.5%	3.0%	10.0%
Greater Asia/Africa	6.5%	4.0%	0.5%	11.0%
Total Oral, Personal and Home Care	3.5%	5.0%	0.5%	9.0%
Pet Nutrition	1.5%	4.0%	0.0%	5.5%
Total Company	3.5%	4.5%	0.5%	8.5%

The following table provides a quantitative reconciliation of various non-GAAP financial measures to the most directly comparable GAAP financial measures for the three months ended September 30, 2011 and 2010.

	2011															2010
	As Reported			Gain on Colombia Brand Sale1			Business Realignment Initiatives2			Mexico Land Sale3			As Adjusted Non- GAAP			As Reported
Cost of Sales	$	1,921					$	28					$	1,893		$	1,599
Gross Profit	2,462						(28		)				2,490			2,344
Gross profit margin	56.2		%										56.8		%	59.4		%
Selling, general and administrative expenses	1,489						5						1,484			1,391
Other (income) expense, net	(62		)	$	(207	)	135			$	7		3			(5		)
Operating profit	1,035			207			(168		)	(7		)	1,003			958
Operating profit margin	23.6		%										22.9		%	24.3		%
Income before income taxes	1,025			207			(168		)	(7		)	993			945
Provisions for income taxes	349			72			(39		)	(2		)	318			300
Effective Tax Rate	34.0		%										32.0		%	31.7		%
Net income including noncontrolling interests	676			135			(129		)	(5		)	675			645
Net income attributable to Colgate-Palmolive Company	$	643		$	135		$	(128	)	$	(5	)	$	641		$	619
Earnings per common share4
Basic	$	1.32		$	0.28		$	(0.26	)	$	(0.01	)	$	1.32		$	1.26
Diluted	$	1.31		$	0.27		$	(0.26	)	$	(0.01	)	$	1.31		$	1.21
1 Represents the gain on the sale of the Company's laundry detergent brands in Colombia.
2 Represents costs associated with various business realignment and other cost-saving initiatives.
3 Represents costs related to the sale of land in Mexico.
4 The impact of non-GAAP adjustments on basic and diluted earnings per share may not necessarily equal the difference between "As Reported" and "As Adjusted Non-GAAP" as a result of rounding.

29

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

The following table provides a quantitative reconciliation of various non-GAAP financial measures to the most directly comparable GAAP financial measures for the nine months ended September 30, 2011 and 2010.

	2011															2010
	As Reported			Gain on Colombia Brand Sale1			Business Realignment Initiatives2			Mexico Land Sale3			As Adjusted Non- GAAP			As Reported4			Venezuela Hyper-inflationary5			As Adjusted Non-GAAP4
Cost of Sales	$	5,365					$	28					$	5,337		$	4,732					$	4,732
Gross Profit	7,197						(28		)				7,225			6,854						6,854
Gross profit margin	57.3		%										57.5		%	59.2		%				59.2		%
Selling, general and administrative expenses	4,314						5						4,309			4,038						4,038
Other (income) expense, net	(35		)	$	(207	)	135			$	7		30			232			$	271		(39		)
Operating profit	2,918			207			(168		)	(7		)	2,886			2,584			(271		)	2,855
Operating profit margin	23.2		%										23.0		%	22.3		%				24.6		%
Income before income taxes	2,881			207			(168		)	(7		)	2,849			2,541			(271		)	2,812
Provisions for Income taxes	952			72			(39		)	(2		)	921			879						879
Effective tax rate	33.0		%										32.3		%	34.6		%				31.3		%
Net income including noncontrolling interests	1,929			135			(129		)	(5		)	1,928			1,662			(271		)	1933
Net income attributable to Colgate-Palmolive Company	$	1,841		$	135		$	(128	)	$	(5	)	$	1,839		$	1,579		$	(271	)	$	1,850
Earnings per common share6
Basic	$	3.76		$	0.28		$	(0.26	)	$	(0.01	)	$	3.75		$	3.17		$	(0.55	)	$	3.72
Diluted	$	3.73		$	0.27		$	(0.26	)	$	(0.01	)	$	3.73		$	3.07		$	(0.52	)	$	3.59
1 Represents the gain on the sale of the Company's laundry detergent brands in Colombia.
2 Represents costs associated with various business realignment and other cost-saving initiatives.
3 Represents costs related to the sale of land in Mexico.
4 Includes a $46 pretax ($59 aftertax, $0.11 diluted earnings per share) gain related to the remeasurement of the Venezuelan balance sheet and lower taxes on accrued but unpaid remittances as a result of the currency devaluation on January 8, 2010.
5 Represents the one-time charge related to the transition to hyperinflationary accounting in Venezuela as of January 1, 2010. This amount primarily represents the premium paid to acquire U.S. dollar-denominated cash and bonds. Prior to January 1, 2010, these assets had been remeasured at the parallel market rate and then translated for financial reporting purposes at the official rate of 2.15.
6 The impact of non-GAAP adjustments on basic and diluted earnings per share may not necessarily equal the difference between "As Reported" and "As Adjusted Non-GAAP" as a result of rounding.

30

COLGATE-PALMOLIVE COMPANY

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in Millions Except Share and Per Share Amounts)

Cautionary Statement on Forward-Looking Statements

This Quarterly Report on Form 10-Q may contain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995 or by the SEC in its rules, regulations and releases. Such statements may relate, for example, to sales or volume growth, organic sales growth, profit or profit margin growth, earnings growth, financial goals, the impact of currency devaluations and exchange controls, in particular, in Venezuela, cost-reduction plans, tax rates, new product introductions or commercial investment levels, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of those statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. Actual events or results may differ materially because of factors that affect international businesses and global economic conditions, as well as matters specific to us and the markets we serve, including the uncertain economic environment in different countries and its effect on consumer spending habits, increased competition and evolving competitive practices, currency rate fluctuations, exchange controls, changes in foreign or domestic laws or regulations or their interpretation, political and fiscal developments, the availability and cost of raw and packaging materials, our ability to maintain or increase selling prices as needed, changes in the policies of retail trade customers and our ability to continue lowering costs. For information about these and other factors that could impact our business and cause actual results to differ materially from forward-looking statements, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2010, including the information set forth under the captions “Item 1A. Risk Factors” and “Cautionary Statement on Forward-Looking Statements.”

Quantitative and Qualitative Disclosures about Market Risk

There is no material change in the information reported under Part II, Item 7, “Managing Foreign Currency, Interest Rate and Commodity Price Exposure” contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2010.

31

COLGATE-PALMOLIVE COMPANY

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company’s management, under the supervision and with the participation of the Company’s Chairman of the Board, President and Chief Executive Officer and its Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of September 30, 2011 (the Evaluation). Based upon the Evaluation, the Company’s Chairman of the Board, President and Chief Executive Officer and its Chief Financial Officer concluded that the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) are effective.

Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

For information regarding legal matters, please refer to Item 3 in the Company’s Annual Report on Form 10-K for the year ended December 31, 2010, Note 13 to the Consolidated Financial Statements included therein and Note 9 to the Condensed Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q.

Item 1A.Risk Factors

For information regarding risk factors, please refer to Part 1, Item 1A in the Company’s Annual Report on Form 10-K for the year ended December 31, 2010.

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

Shares repurchased from July 1, 2011 through September 8, 2011 were repurchased pursuant to a program authorized by the Company’s Board of Directors on February 4, 2010 (the 2010 Program). On September 8, 2011, the Board authorized a new share repurchase program (the 2011 Program). The 2011 Program authorizes the repurchase of up to 50 million shares of the Company’s common stock. The Board also has authorized share repurchases on an on-going basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares will be repurchased from time to time in open market transactions or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

32

COLGATE-PALMOLIVE COMPANY

The following table shows the stock repurchase activity for each of the three months in the quarter ended September 30, 2011:

Month	Total Number of Shares Purchased(1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs(3)
July 1 through 31, 2011	580,839	$	87.32	460,000	4,349,520
August 1 through 31, 2011	1,844,397	$	85.42	1,820,000	2,529,520
September 1 through 30, 2011	1,773,624	$	90.35	1,705,511	48,699,489
Total	4,198,860	$	87.76	3,985,511

_______

⁽¹⁾  Includes share repurchases under the 2010 Program and the 2011 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.

⁽²⁾  The difference between the total number of shares purchased and the total number of shares purchased as part of publicly announced plans or programs is 213,349 shares, all of which relate to shares deemed surrendered to the Company to satisfy certain employee elections under its compensation and benefit programs.

⁽³⁾  In September, 405,000 shares were repurchased under the 2010 Program. Beginning on September 9, 2011, the maximum number of shares reflects the 50 million shares authorized for repurchase under the 2011 Program less the cumulative number of shares that have been purchased under the 2011 Program.

Item 3.Defaults Upon Senior Securities

None.

Item 5.Other Information

None.

33

COLGATE-PALMOLIVE COMPANY

Item 6.Exhibits

Exhibit No.	Description
10-A	Amendment, dated July 14, 2011, to the Colgate-Palmolive Company 2005 Non-Employee Director Stock Option Plan.
10-B	Amendment, dated July 14, 2011, to the Colgate-Palmolive Company 2005 Employee Stock Option Plan.
12	Computation of Ratio of Earnings to Fixed Charges.
31-A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
31-B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
32	Certificate of the Chairman of the Board, President and Chief Executive Officer and the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350.
101	The following materials from Colgate-Palmolive Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2011, formatted in eXtensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Income, (ii) the Condensed Consolidated Balance Sheets, (iii) the Condensed Consolidated Statements of Cash Flows, and (iv) Notes to Condensed Consolidated Financial Statements.

34

COLGATE-PALMOLIVE COMPANY

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	COLGATE-PALMOLIVE COMPANY
	(Registrant)
	Principal Executive Officer:
October 27, 2011	/s/ Ian Cook
	Ian Cook
	Chairman of the Board, President and Chief Executive Officer
	Principal Financial Officer:
October 27, 2011	/s/ Dennis J. Hickey
	Dennis J. Hickey
	Chief Financial Officer
	Principal Accounting Officer:
October 27, 2011	/s/ Victoria L. Dolan
	Victoria L. Dolan
	Vice President and Corporate Controller

35

EX-10.A

EXHIBIT 10-A

Amendment, dated July 14, 2011, to the

Colgate-Palmolive Company 2005 Non-Employee Director Stock Option Plan

At a meeting held on July 14, 2011, the Board of Directors of Colgate-Palmolive Company determined to amend the Colgate-Palmolive Company 2005 Non-Employee Director Stock Option Plan to modify certain provisions to contemplate the administration of equity awards by third party service providers and to allow for the electronic delivery of documents, and approved the following resolutions:

RESOLVED, that Section 5(c)(iii) of the Plan be and hereby is amended so that as amended it shall read in full as follows:

(iii) Method of Exercise. Subject to the provisions of this Section 5, Stock Options may be exercised, in whole or in part, at any time during the option term by providing notice of exercise specifying the number of shares of Common Stock as to which the Stock Option is being exercised. Such notice shall be provided in a form and manner acceptable to the Company.

Such notice shall be accompanied by payment in full of the purchase price by certified or bank check or such other instrument or form of payment as the Company may accept. Payment in full or in part may also be made in the form of Common Stock already owned by the optionee of the same class as the Common Stock subject to the Stock Option. Payment in full or part may also be made by requesting that sufficient shares to pay such purchase price (based on the Fair Market Value of the Common Stock on the date of exercise) be withheld from the shares of Common Stock subject to the Stock Options.

No shares of Common Stock shall be issued until full payment therefor has been made. An optionee shall have all of the rights of a stockholder of the Company holding the class or series of Common Stock that is subject to such Stock Option (including, if applicable, the right to vote the shares and the right to receive dividends), when the optionee has given written notice of exercise, has paid in full for such shares and, has given the representation described in Section 8(a).

; and be it further

RESOLVED, that the Plan be and hereby is amended so that as amended it shall include a new Section 8(d) as follows:

(d) Electronic documents may be substituted for any written materials to be delivered in connection with the Plan, including, without limitation, Plan documents and notices of exercise.

EX-10.B

EXHIBIT 10-B

Amendment, dated July 14, 2011, to the

Colgate-Palmolive Company 2005 Employee Stock Option Plan

At a meeting held on July 14, 2011, the Board of Directors of Colgate-Palmolive Company determined to amend the Colgate-Palmolive Company 2005 Employee Stock Option Plan to modify certain provisions to contemplate the administration of equity awards by third party service providers and to allow for the electronic delivery of documents, and approved the following resolutions:

RESOLVED, that Section 5(b) of the Plan be and hereby is amended so that as amended it shall read in full as follows:

(b) Award Agreements. Awards shall be evidenced by award agreements, the terms and provisions of which may differ. An award agreement for a Stock Option shall indicate on its face whether it is intended to be an agreement for an Incentive Stock Option or a Nonqualified Stock Option. The grant of an Award shall occur on the date the Committee, by resolution, selects an individual to be a Participant in any grant of an Award, determines the number of shares of Common Stock to be subject to such Award to be granted to such individual and specifies the terms and provisions of the Award. The Participant shall be notified of any grant of an Award, and an award agreement or agreements shall be delivered to the Participant. Such agreement or agreements shall become effective upon the Participant's acceptance of the terms and conditions contained in the agreement.

; and be it further

    RESOLVED, that Section 5(c)(4) of the Plan be and hereby is amended so that as amended it shall read in full as follows:

(4) Method of Exercise. (i) Subject to the provisions of this Section 5, Stock Options and Free-Standing SARs may be exercised, in whole or in part, at any time during the applicable award term by providing notice of exercise specifying the number of shares of Common Stock as to which the Stock Option or Free-Standing SAR is being exercised. Such notice shall be provided in a form and manner acceptable to the Company.

(ii) In the case of an exercise of a Stock Option, such notice shall be accompanied by payment in full of the purchase price by certified or bank check or such other instrument or form of payment as the Company may accept. Unless otherwise determined by the Committee, such payment may also be made in full or in part in the form of unrestricted Common Stock (by delivery of the shares or attestation) already owned by the Participant of the same class as the Common Stock subject to the Stock Option (based on the Fair Market Value of the Common Stock on the date the Stock Option is exercised); provided, however, that, in the case of an Incentive Stock Option, the right to make payment in the form of already owned shares of Common Stock may be authorized only at the time the Stock Option is granted.

To the extent permitted by applicable law, the Company may make loans to such Participants as the Committee, in its discretion, may determine in connection with the exercise of Stock Options in an amount up to the exercise price of the Stock Option to be exercised plus any applicable withholding taxes. In no event may any such loan exceed the Fair Market Value, at the date of exercise, of the shares covered by the Stock Option, or portion thereof, exercised by the Participant. Such loans shall be subject to such terms and conditions as the Committee shall determine. Every loan shall comply with all applicable laws, regulations and rules of the Federal Reserve Board and any other governmental agency having jurisdiction.

To the extent permitted by applicable law, unless otherwise determined by the Committee, payment for any shares subject to a Stock Option may also be made by delivering a notice of exercise in a form and manner acceptable to the Company, together with irrevocable instructions to a broker to deliver promptly to the Company the amount of sale or loan proceeds to pay the purchase price, and, if requested, by the amount of any federal, state, local or foreign withholding taxes. To facilitate the foregoing, the Company may, to the extent permitted by applicable law, enter into agreements for coordinated procedures with one or more brokerage firms.

No shares of Common Stock shall be issued upon exercise of a Stock Option until full payment therefor has been made. An optionee shall have all of the rights of a shareholder of the Company holding the class or series of Common Stock that is subject to such Stock Option (including, if applicable, the right to vote the shares and the right to receive dividends), when the optionee has given written notice of exercise, has paid in full for such shares and, if requested, has given the representation described in Section 10(a).

; and be it further

RESOLVED, that the Plan be and hereby is amended so that as amended it shall include a new Section 10(j) as follows:

(j) Electronic documents may be substituted for any written materials to be delivered in connection with the Plan, including, without limitation, Plan and Award documents, award agreements and notices of exercise.

EX-12

EXHIBIT 12

COLGATE-PALMOLIVE COMPANY

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

(Dollars in Millions Except as Indicated)

(Unaudited)

	Nine Months Ended September 30, 2011
Earnings:
Income before income taxes	$	2,881
Add:
Interest on indebtedness and amortization of debt expense and discount or premium	42
Portion of rents representative of interest factor	55
Less:
Gain on equity investments	(5		)
Income as adjusted	$	2,973
Fixed Charges:
Interest on indebtedness and amortization of debt expense and discount or premium	42
Portion of rents representative of interest factor	55
Capitalized interest	—
Total Fixed Charges	$	97
Ratio of earnings to fixed charges	30.6

EX-31.A

EXHIBIT 31-A

I, Ian Cook, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Colgate-Palmolive Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: October 27, 2011

/s/ Ian Cook

Ian Cook

Chairman of the Board, President and

Chief Executive Officer

EX-31.B

EXHIBIT 31-B

I, Dennis J. Hickey, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Colgate-Palmolive Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: October 27, 2011

/s/ Dennis J. Hickey

Dennis J. Hickey

Chief Financial Officer

EX-32

EXHIBIT 32

The undersigned Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer of Colgate-Palmolive Company each certify, pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350, that:

(1) the Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2011 (the “Periodic Report”) which this statement accompanies fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2) information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Colgate-Palmolive Company.

Date: October 27, 2011

/s/ Ian Cook

Ian Cook

Chairman of the Board, President and

Chief Executive Officer

/s/ Dennis J. Hickey

Dennis J. Hickey

Chief Financial Officer

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $) In Millions	Sep. 30, 2011	Dec. 31, 2010
Current Assets
Cash and cash equivalents	$ 945	$ 490
Receivables (net of allowances of $52 and $53, respectively)	1,677	1,610
Inventories	1,336	1,222
Other current assets	485	408
Total current assets	4,443	3,730
Property, plant and equipment:
Cost	7,229	7,160
Less: Accumulated depreciation	(3,614)	(3,467)
Property, plant and equipment, net	3,615	3,693
Goodwill, net	2,694	2,362
Other intangible assets, net	1,424	831
Deferred income taxes	91	84
Other assets	501	472
Total assets	12,768	11,172
Current Liabilities
Notes and loans payable	67	48
Current portion of long-term debt	921	561
Accounts payable	1,150	1,165
Accrued income taxes	379	272
Other accruals	1,800	1,682
Total current liabilities	4,317	3,728
Long-term debt	3,768	2,815
Deferred income taxes	275	108
Other liabilities	1,538	1,704
Shareholders' Equity
Common stock	733	733
Additional paid-in capital	1,268	1,132
Retained earnings	15,344	14,329
Accumulated other comprehensive income (loss)	(2,199)	(2,115)
Shareholders' Equity Before Unearned Compensation Treasury Stock And Noncontrolling Interest	15,146	14,079
Unearned compensation	(59)	(99)
Treasury stock, at cost	(12,420)	(11,305)
Total Colgate-Palmolive Company shareholders' equity	2,667	2,675
Noncontrolling interests	203	142
Total shareholders' equity	2,870	2,817
Total liabilities and shareholders' equity	$ 12,768	$ 11,172

XML

CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parentheticals) (USD $) In Millions	Sep. 30, 2011	Dec. 31, 2010
Current Assets
Receivables (net of allowances)	$ 52	$ 53

XML

Retirement Plans and Other Retiree Benefits (Tables)

9 Months Ended

Sep. 30, 2010

Notes to Financial Statements [Abstract]

Components Of Net Periodic Benefit Cost

Components of net periodic benefit cost for the three and nine months endedSeptember 30, 2011 and 2010 were as follows: 

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended September 30,
	2011			2010			2011			2010			2011			2010
Service cost	$	5		$	11		$	6		$	4		$	2		$	3
Interest cost	24			23			9			9			8			9
Annual ESOP allocation	—			—			—			—			—			(1		)
Expected return on plan assets	(27		)	(25		)	(7		)	(7		)	(1		)	(1		)
Amortization of transition and prior service costs (credits)	2			1			—			1			—			—
Amortization of actuarial loss	12			13			2			2			3			4
Net periodic benefit cost	$	16		$	23		$	10		$	9		$	12		$	14

	Pension Benefits												Other Retiree Benefits
	United States						International
	Nine Months Ended September 30,
	2011			2010			2011			2010			2011			2010
Service cost	$	18		$	36		$	16		$	13		$	8		$	10
Interest cost	75			71			28			26			29			30
Annual ESOP allocation	—			—			—			—			(1		)	(5		)
Expected return on plan assets	(83		)	(76		)	(21		)	(19		)	(2		)	(2		)
Amortization of transition and prior service costs (credits)	7			3			2			1			3			—
Amortization of actuarial loss	35			35			7			7			12			11
Net periodic benefit cost	$	52		$	69		$	32		$	28		$	49		$	44

XML

Document and Entity Information Document	9 Months Ended
	Sep. 30, 2011
Entity Information [Line Items]
Entity Registrant Name	COLGATE PALMOLIVE CO
Entity Central Index Key	0000021665
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding	483,999,297
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2011

XML

Acquisitions and Divestitures (Details) In Millions, unless otherwise specified	3 Months Ended	9 Months Ended		3 Months Ended	9 Months Ended	12 Months Ended					3 Months Ended
	Sep. 30, 2011 USD ($)	Sep. 30, 2011 USD ($)	Sep. 30, 2010 USD ($)	Sep. 30, 2011 Sanex Personal Care Business [Member] USD ($)	Sep. 30, 2011 Sanex Personal Care Business [Member] USD ($)	Dec. 31, 2010 Sanex Personal Care Business [Member] USD ($)	Dec. 31, 2010 Sanex Personal Care Business [Member] EUR (€)	Jun. 20, 2011 Sanex Personal Care Business [Member] USD ($)	Jun. 20, 2011 Sanex Personal Care Business [Member] EUR (€)	Jun. 20, 2011 Sanex Personal Care Business [Member] Trademarks [Member] USD ($)	Jun. 30, 2011 Sanex Personal Care Business [Member] Customer Relationships [Member] years	Jun. 20, 2011 Sanex Personal Care Business [Member] Customer Relationships [Member] USD ($)
Sale of brands [Abstract]
Proceeds from sale of brands	$ 215
Pretax gain from the sale of Colombia brands	207	207	0
Aftertax gain from the sale of Colombia brands	135
Sale of Land in Mexico [Abstract]
First Installment received from the sale of land in Mexico	24
Pretax costs related to sale of land	7	7
Aftertax costs related to sale of land	5
Business Acquisition [Line Items]
Aggregate purchase price								960	672
Net sales						265	187
Recognized amounts of assets acquired and liabilities assumed [Abstract]
Inventories								21
Property, plant and equipment, net								7
Other intangible assets, net								605
Goodwill, net								411
Accrued income taxes								(80)
Long-term other liabilities								(4)
Fair value of net assets acquired								960
Acquired indefinite-lived intangible assets										425
Acquired finite-lived intangible assets												180
Useful lives, lower range (in years)											12
Useful lives, higher range (in years)											14
Transaction costs				$ 2	$ 12

XML

Earnings Per Share

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Earnings Per Share

Earnings Per Share

	Three Months Ended
	September 30, 2011					September 30, 2010
	Income		Shares (millions)	Per Share		Income			Shares (millions)	Per Share
Net income attributable to Colgate-Palmolive Company	$	643				$	619
Preferred dividends	—					(9		)
Basic EPS	643		486.7	$	1.32	610			486.0	$	1.26
Stock options and restricted stock			3.8						3.8
Convertible preference stock	—		—			9			19.7
Diluted EPS	$	643	490.5	$	1.31	$	619		509.5	$	1.21

For the three months ended September 30, 2011 and 2010, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 1,202,090 and 4,248,553, respectively.

	Nine Months Ended
	September 30, 2011					September 30, 2010
	Income		Shares (millions)	Per Share		Income			Shares (millions)	Per Share
Net income attributable to Colgate-Palmolive Company	$	1,841				$	1,579
Preferred dividends	—					(25		)
Basic EPS	1,841		489.9	$	3.76	1,554			489.9	$	3.17
Stock options and restricted stock			3.5						4.7
Convertible preference stock	—		—			25			20.1
Diluted EPS	$	1,841	493.4	$	3.73	$	1,579		514.7	$	3.07

For the nine months endedSeptember 30, 2011 and 2010, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 422,263 and 49,904, respectively.

As a result of recent rules issued by the Internal Revenue Service related to employer stock held in defined contribution plans, the Company issued a notice of redemption with respect to the 2,405,192 shares of preference stock outstanding on December 29, 2010.  At the direction of the Company’s ESOP trustee, the shares of preference stock were converted into 19,241,536 shares of common stock.

XML

Acquisitions and Divestitures (Details 1)	Jun. 20, 2011
Europe/South Pacific [Member]
Indefinite-lived Intangible Assets by Segment [Line Items]
Allocation of goodwill (in hundreths)	95.00%
Greater Asia/Africa [Member]
Indefinite-lived Intangible Assets by Segment [Line Items]
Allocation of goodwill (in hundreths)	5.00%

XML

Financial Instruments and Fair Value Measurements (Details 4) (USD $) In Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2011	Dec. 31, 2010 Investment Grade Fixed Income Securities [Member]	Sep. 30, 2011 US Dollar-Linked, Devaluation-Protected Bonds Issued By Venezuelan Government [Member]	Sep. 30, 2010 US Dollar-Linked, Devaluation-Protected Bonds Issued By Venezuelan Government [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair value		$ 132	$ 233
Venezuelan Investments [Roll Forward]
Beginning balance			96	46
Unrealized gain (loss) on investment			60	(19)
Purchases and sales during the period			77	23
Ending balance			233	50
Unrealized gain on investment	$ 62

XML

Financial Instruments and Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Schedule of derivative instruments

The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at September 30, 2011 and December 31, 2010:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		9/30/11		12/31/10			9/30/11		12/31/10
Interest rate swap contracts	Other current assets & Other assets	$	45	$	22	Other liabilities	$	—	$	7
Foreign currency contracts	Other current assets	8		10		Other accruals	8		10
Commodity contracts	Other current assets	—		4		Other accruals	3		—
Total designated		$	53	$	36		$	11	$	17
Derivatives not designated
Foreign currency contracts	Other assets	$	2	$	—	Other accruals	$	—	$	2
Total not designated		$	2	$	—		$	—	$	2
Total derivative instruments		$	55	$	36		$	11	$	19
Other financial instruments
Marketable securities	Other current assets	$	72	$	74
Available-for-sale securities	Other assets	233		228
Total other financial instruments		$	305	$	302

Activity related to fair value hedges

Activity related to fair value hedges recorded during the three-month and nine-month periods ended September 30, 2011 and 2010 was as follows:

	2011									2010
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at September 30	$	619		$	1,288		$	1,907		$	1,080		$	600		$	1,680
Three-months ended September 30:
Gain (loss) on derivative	—			22			22			26			4			30
Gain (loss) on hedged items	—			(22		)	(22		)	(26		)	(4		)	(30		)
Nine-months ended September 30:
Gain (loss) on derivative	6			30			36			22			13			35
Gain (loss) on hedged items	(6		)	(30		)	(36		)	(22		)	(13		)	(35		)

Activity related to cash flow hedges

Activity related to cash flow hedges recorded during the three-month and nine-month periods ended September 30, 2011 and 2010 was as follows:

	2011									2010
	Foreign Currency Contracts			Commodity Contracts			Total			Foreign Currency Contracts			Commodity Contracts			Total
Notional Value at September 30	$	326		$	32		$	358		$	292		$	16		$	308
Three-months ended September 30:
Gain (loss) recognized in OCI	(2		)	(2		)	(4		)	(11		)	5			(6		)
Gain (loss) reclassified into Cost of sales	(5		)	1			(4		)	(3		)	—			(3		)
Nine-months ended September 30:
Gain (loss) recognized in OCI	(9		)	(2		)	(11		)	(10		)	2			(8		)
Gain (loss) reclassified into Cost of sales	(13		)	6			(7		)	—			(1		)	(1		)

Activity related to net investment hedges

Activity related to net investment hedges recorded during the three-month and nine-month periods ended September 30, 2011 and 2010 was as follows:

	2011									2010
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at September 30	$	32		$	348		$	380		$	76		$	279		$	355
Three-months ended September 30:
Gain (loss) on instruments	2			23			25			(10		)	(31		)	(41		)
Gain (loss) on hedged items	(2		)	(23		)	(25		)	10			31			41
Nine-months ended September 30:
Gain (loss) on instruments	(8		)	(10		)	(18		)	(6		)	3			(3		)
Gain (loss) on hedged items	8			10			18			6			(3		)	3

Activity related to derivatives not designated as hedging instruments

Activity related to these contracts during the three-month and nine-month periods ended September 30, 2011 and 2010 was as follows:

	2011			2010
	Cross-currency Swap			Cross-currency Swap
Notional Value at September 30	$	96		$	90
Three-months ended September 30:
Gain (loss) on instrument	2			(5		)
Gain (loss) on hedged item	(2		)	5
Nine-months ended September 30:
Gain (loss) on instrument	(2		)	1
Gain (loss) on hedged item	2			(1		)

Reconciliation of the Venezuelan investments at fair value

The following table presents a reconciliation of the Venezuelan investments at fair value for the nine months ended September 30:

	2011		2010
Beginning balance as of January 1	$	96	$	46
Unrealized gain (loss) on investment	60		(19		)
Purchases and sales during the period	77		23
Ending balance as of September 30	$	233	$	50

XML

Venezuela

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Venezuela

Venezuela

Effective January 1, 2010, Venezuela was designated as hyperinflationary and therefore the functional currency for the Company’s Venezuelan subsidiary (CP Venezuela) became the U.S. dollar. As a result, the impact of Venezuelan currency fluctuations is reported in income. The change in the reporting currency from the Venezuelan bolivar fuerte to the U.S. dollar resulted in a one-time charge of $271 recorded within Other (income) expense, net in the first quarter of 2010. This charge primarily represented the premium paid to acquire U.S. dollar-denominated cash ($150) and bonds ($152) at the parallel market rate, offset by $31 for U.S. dollar-denominated payables. Previously these items had been remeasured at the parallel market rate and then translated for financial reporting purposes at the official rate of 2.15.

On January 8, 2010, the Venezuelan government announced its decision to devalue its currency and implement a two-tier exchange rate structure. As a result, the official exchange rate changed from 2.15 to 2.60 for essential goods and 4.30 for non-essential goods. The devaluation resulted in a one-time pretax gain of $46 recorded in Other (income) expense and an aftertax gain of $59 in the first quarter of 2010 related to the remeasurement of the local balance sheet and lower taxes on accrued but unpaid remittances from Venezuela. In December 2010, the Venezuelan government announced that, effective January 1, 2011, the 2.60 exchange rate for essential goods would be abolished. As a result, CP Venezuela incurred an aftertax loss of $36 in the fourth quarter of 2010 related to the remeasurement of certain local balance sheet items for which the 2.60 exchange rate would no longer be received. This loss was offset by lower taxes on accrued but unpaid remittances.

The Company remeasures the financial statements of CP Venezuela at the rate at which it expects to remit future dividends, which currently is 4.30. As a result of the devaluations of the Venezuelan bolivar fuerte, the local currency operations of CP Venezuela now translate into fewer U.S. dollars.

For the nine months ended September 30, 2011, CP Venezuela represented 5% of the Company’s consolidated Net sales. At September 30, 2011, CP Venezuela’s bolivar fuerte-denominated monetary net asset position was approximately $277 which does not include $233 of devaluation-protected bonds issued by the Venezuelan government, as these bonds provide protection against devaluations by adjusting the amount of bolivares fuertes received at maturity for any devaluation subsequent to issuance. As described in Note 11, these bonds are considered a Level 2 investment.

XML

Acquisitions and Divestitures

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Acquisitions and Divestitures

Acquisitions and Divestitures

Sanex Acquisition

On June 20, 2011, the Company, Colgate-Palmolive Europe Sàrl, Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever”) finalized the Company’s acquisition from Unilever of the Sanex personal care business in accordance with a Business and Share Sale and Purchase Agreement (the “Purchase Agreement”) for an aggregate purchase price of €672 ($960), subject to certain post-closing purchase price adjustments. The acquisition was financed with available cash, proceeds from the sale of the Company’s Euro-denominated investment portfolio and the issuance of commercial paper.

Sanex is a personal care brand with a distinct positioning around healthy skin with strong market share positions and 2010 net sales of €187 (approximately $265), primarily in Western Europe.  This strategic acquisition is expected to strengthen Colgate’s personal care business in Europe, primarily in the liquid body cleansing and deodorants businesses.

Total purchase price consideration of $960 has been allocated on a preliminary basis to the net assets acquired based on their respective estimated fair values at June 20, 2011, as follows:

Recognized amounts of assets acquired and liabilities assumed:
Inventories	$	21
Property, plant and equipment, net	7
Other intangible assets, net	605
Goodwill, net	411
Accrued income taxes	(80		)
Long-term other liabilities	(4		)
Fair value of net assets acquired	$	960

Other intangible assets acquired include trademarks of $425 with an indefinite useful life and customer relationships of $180 with useful lives ranging from 12 to 14 years.

Goodwill of $411 was allocated between the Europe/South Pacific segment (95%) and the Greater Asia/Africa segment (5%). The Company expects that substantially all of the goodwill will be deductible for tax purposes.

The preliminary estimates of the fair value of identifiable assets acquired and liabilities assumed are subject to revisions, which may result in adjustments to the preliminary values discussed above.

Pro forma results of operations have not been presented, as the impact on the Company’s consolidated financial statements is not material. The Company expects to finalize the purchase price allocation by the end of 2011. For the nine months ended September 30, 2011, Other (income) expense, net includes $12 in transaction costs related to the acquisition, of which $2 relates to the third quarter.

Pursuant to the Purchase Agreement, Colgate and Unilever also entered into a Transition Services Agreement, under which Unilever agreed to provide certain transitional services in various countries for up to six months following the closing, and a Supply Agreement, pursuant to which Unilever will supply certain Sanex products to Colgate for up to two years following the closing.

Sale of Brands in Colombia

In connection with the Sanex acquisition, Colgate sold its laundry detergent brands in Colombia to Unilever for $215. The detergent sale closed on July 29, 2011 and, as a result of the sale, the Company recognized a pretax gain of $207 ($135 aftertax gain) in the third quarter.

Sale of Land in Mexico

On September 13, 2011, the Company's Mexican subsidiary entered into an agreement to sell the Mexico City site on which its commercial operations, technology center and soap production facility are located. The sale price is payable in three installments, with the final installment due upon the transfer of the property, which is expected to occur in 2014. During the third quarter of 2011, the Company received the first installment of $24 upon signing the agreement. The Company intends to re-invest these payments to relocate its soap production to a new state-of-the-art facility to be constructed at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. As a result, over the next three years, the Company expects to make capital improvements and incur costs to exit the site. These exit costs will primarily be related to staff leaving indemnities, accelerated depreciation and demolition. During the three months ended September 30, 2011, the Company recorded $7 of pretax costs ($5 aftertax costs) related to the sale in Other (income) expense, net.

XML

Financial Instruments and Fair Value Measurements (Details 1) (USD $) In Millions	Sep. 30, 2011	Dec. 31, 2010
Derivative Instruments [Abstract]
Designated asset derivative instruments	$ 53	$ 36
Asset derivatives not designated	2	0
Total asset derivatives	55	36
Designated liability derivative instruments	11	17
Liability derivatives not designated	0	2
Total liability derivatives	11	19
Fair Value, Inputs, Level 1 [Member] | Financial Instruments Recorded In Other Current Assets [Member]
Financial Instruments [Abstract]
Marketable securities	72	74
Fair Value [Member]
Financial Instruments [Abstract]
Total other financial instruments	305	302
Fair Value [Member] | Financial Instruments Recorded In Other Assets [Member]
Financial Instruments [Abstract]
Available-for-sale securities	233	228
Interest Rate Swap Contracts [Member] | Other current assets and Other assets [Member]
Derivative Instruments [Abstract]
Designated asset derivative instruments	45
Interest Rate Swap Contracts [Member] | Other Assets [Member]
Derivative Instruments [Abstract]
Designated asset derivative instruments		22
Interest Rate Swap Contracts [Member] | Other Liabilities [Member]
Derivative Instruments [Abstract]
Designated liability derivative instruments	0	7
Foreign Currency Contracts [Member] | Other Assets [Member]
Derivative Instruments [Abstract]
Asset derivatives not designated	2	0
Foreign Currency Contracts [Member] | Other Current Assets [Member]
Derivative Instruments [Abstract]
Designated asset derivative instruments	8	10
Foreign Currency Contracts [Member] | Other Accruals [Member]
Derivative Instruments [Abstract]
Designated liability derivative instruments	8	10
Liability derivatives not designated	0	2
Commodity Contracts [Member] | Other Current Assets [Member]
Derivative Instruments [Abstract]
Designated asset derivative instruments	0	4
Commodity Contracts [Member] | Other Accruals [Member]
Derivative Instruments [Abstract]
Designated liability derivative instruments	$ 3	$ 0

XML

Contingencies

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Contingencies

Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, environmental and tax matters. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

As a matter of course, the Company is regularly audited by the IRS and other tax authorities around the world in countries where it conducts business. In this regard, the IRS has completed its examination of the Company’s federal income tax returns through 2005. Estimated incremental tax payments related to potential disallowances for subsequent periods are not expected to be material.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $250 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more of these matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

Brazilian Matters

In 2001, the Central Bank of Brazil sought to impose a substantial fine on the Company’s Brazilian subsidiary based on alleged foreign exchange violations in connection with the financing of the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (formerly American Home Products) (the Seller), as described in the Company’s Form 8-K dated January 10, 1995. The Company appealed the imposition of the fine to the Brazilian Monetary System Appeals Council (the Council), and on January 30, 2007, the Council decided the appeal in the Company’s favor, dismissing the fine entirely. However, certain tax and civil proceedings that began as a result of this Central Bank matter are still outstanding as described below.

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, at the current exchange rate, approximate $113. The Company has been disputing the disallowances by appealing the assessments within the internal revenue authority’s appellate process with the following results to date:

▪ In June 2005, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1996 through 1998. In March 2007, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1999 through 2001. The tax authorities appealed these decisions to the next administrative level.

▪ In August 2009, the First Taxpayers’ Council (the next and final administrative level of appeal) overruled the decisions of the First Board of Taxpayers, upholding the majority of the assessments, disallowing a portion of the assessments and remanding a portion of the assessments for further consideration by the First Board of Taxpayers.

The Company has filed a motion for reconsideration with the First Taxpayers’ Council and further appeals are available within the Brazilian federal courts. The Company intends to challenge these assessments vigorously. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel and other advisors, that the disallowances are without merit and that the Company should ultimately prevail on appeal, if necessary, in the Brazilian federal courts.

In 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company intends to challenge this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest and penalties of approximately $67, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company is disputing the assessment within the internal revenue authority’s administrative appeals process. In October 2007, the Second Board of Taxpayers, which has jurisdiction over these matters, ruled in favor of the internal revenue authority. In January 2008, the Company appealed this decision to the next administrative level. Although there can be no assurances, management believes, based on the advice of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should prevail on appeal either at the administrative level or, if necessary, in the Brazilian federal courts. The Company intends to challenge this assessment vigorously.

European Competition Matters

Since February 2006, the Company has learned that investigations relating to potential competition law violations involving the Company’s subsidiaries had been commenced by governmental authorities in a number of European countries and by the European Commission. The Company understands that many of these investigations also involve other consumer goods companies and/or retail customers. The status of the various pending matters is discussed below.

Fines have been imposed on the Company in the following matters, although the Company is appealing these fines:

▪ In December 2009, the Swiss competition law authority imposed a fine of $5 on the Company’s GABA subsidiary for alleged violations of restrictions on parallel imports into Switzerland. The Company is appealing the fine in the Swiss courts.

▪ In January 2010, the Spanish competition law authority found that four suppliers of shower gel had entered into an agreement regarding product down-sizing, for which Colgate’s Spanish subsidiary was fined $3. The Company is appealing the fine in the Spanish courts.

▪ In December 2010, the Italian competition law authority found that 16 consumer goods companies, including the Company’s Italian subsidiary, exchanged competitively sensitive information in the cosmetics sector, for which the Company’s Italian subsidiary was fined $3. The Company is appealing the fine in the Italian courts.

Currently, formal claims of violations, or statements of objections, are pending against the Company as follows:

▪ The French competition authority alleges agreements on pricing and promotion of heavy duty detergents among four consumer goods companies, including the Company’s French subsidiary.

▪ The French competition authority alleges violations of competition law by three pet food producers, including the Company’s Hill’s France subsidiary, focusing on exclusivity arrangements and parallel trade restrictions.

▪ The German competition authority alleges that 17 branded goods companies, including the Company’s German subsidiary, exchanged sensitive information related to the German market.

The Company has responded to each of these formal claims of violations. Investigations are ongoing in Belgium, France and Greece, but no formal claims of violations have been filed in these jurisdictions except in France as noted above.

Since December 31, 2010, the following matters have been resolved:

▪ In April 2011, the investigation by the European Commission was resolved with no formal claims of violations or decisions made against the Company. To the Company’s knowledge, there are no other investigations by the European Commission relating to potential competition law violations involving the Company or its subsidiaries.

▪ In May 2011, the Dutch competition authority closed its investigation and no decision was made against the Company or its Dutch subsidiary.

The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The Company has undertaken a comprehensive review of its selling practices and related competition law compliance in Europe and elsewhere and, where the Company has identified a lack of compliance, it has undertaken remedial action. Competition and antitrust law investigations often continue for several years and can result in substantial fines for violations that are found. Such fines, depending on the gravity and duration of the infringement as well as the value of the sales involved, have amounted, in some cases, to hundreds of millions of dollars. While the Company cannot predict the final financial impact of these competition law issues as these matters may change, the Company evaluates developments in these matters quarterly and accrues liabilities as and when appropriate.

ERISA Matters

In October 2007, a putative class action claiming that certain aspects of the cash balance portion of the Colgate-Palmolive Company Employees’ Retirement Income Plan (the Plan) do not comply with the Employee Retirement Income Security Act was filed against the Plan and the Company in the United States District Court for the Southern District of New York. Specifically, Proesel, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al. alleges improper calculation of lump sum distributions, age discrimination and failure to satisfy minimum accrual requirements, thereby resulting in the underpayment of benefits to Plan participants. Two other putative class actions filed earlier in 2007, Abelman, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al., in the United States District Court for the Southern District of Ohio, and Caufield v. Colgate-Palmolive Company Employees’ Retirement Income Plan, in the United States District Court for the Southern District of Indiana, both alleging improper calculation of lump sum distributions and, in the case of Abelman, claims for failure to satisfy minimum accrual requirements, were transferred to the Southern District of New York and consolidated with Proesel into one action, In re Colgate-Palmolive ERISA Litigation. The complaint in the consolidated action alleges improper calculation of lump sum distributions and failure to satisfy minimum accrual requirements, but does not include a claim for age discrimination. The relief sought includes recalculation of benefits in unspecified amounts, pre- and post-judgment interest, injunctive relief and attorneys’ fees. This action has not been certified as a class action as yet. The parties are in discussions via non-binding mediation to determine whether the action can be settled. The Company and the Plan intend to contest this action vigorously should the parties be unable to reach a settlement.

XML

Inventories (Tables)

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Inventories By Major Class

Inventories by major class are as follows:

	September 30, 2011		December 31, 2010
Raw materials and supplies	$	324	$	295
Work-in-process	60		50
Finished goods	952		877
Total Inventories	$	1,336	$	1,222

XML

Segment Information

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Segment Information

Segment Information

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of the operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes. Corporate operations include stock-based compensation related to stock options and restricted stock awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company in order to measure the underlying performance of the business segments.  

Net sales and Operating profit by segment were as follows:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2011			2010			2011			2010
Net sales
Oral, Personal and Home Care
North America	$	776		$	753		$	2,238		$	2,274
Latin America	1,243			1,069			3,571			3,130
Europe/South Pacific	972			821			2,661			2,415
Greater Asia/Africa	855			779			2,484			2,239
Total Oral, Personal and Home Care	3,846			3,422			10,954			10,058
Pet Nutrition	537			521			1,608			1,528
Total Net sales	$	4,383		$	3,943		$	12,562		$	11,586
Operating profit
Oral, Personal and Home Care
North America	$	213		$	224		$	599		$	668
Latin America	364			332			1,050			975
Europe/South Pacific	196			197			551			572
Greater Asia/Africa	202			195			604			573
Total Oral, Personal and Home Care	975			948			2,804			2,788
Pet Nutrition	127			138			408			413
Corporate	(67		)	(128		)	(294		)	(617		)
Total Operating profit	$	1,035		$	958		$	2,918		$	2,584

For the three and nine months ended September 30, 2011, Corporate Operating profit includes a gain on the sale of the laundry detergent brands in Colombia of $207, costs of $168 associated with various business realignment and other cost-saving initiatives and costs of $7 related to the sale of land in Mexico. The various business realignment and other cost-saving initiatives include the integration of Sanex, the right-sizing of the Colombia business and the closing of an oral care facility in Mississauga, Canada and a Hill’s facility in Los Angeles, California. For further information regarding the sale of land in Mexico, refer to Note 3. In 2010, Corporate Operating profit includes the one-time charge of $271 related to the transition to hyperinflationary accounting in Venezuela as of January 1, 2010. For further information regarding Venezuela, refer to Note 12.

XML

Retirement Plans and Other Retiree Benefits (Details) (USD $) In Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Defined Benefit Plan Disclosure [Line Items]
Voluntary benefit plan contributions			$ (178)	$ (35)
United States Pension Benefits [Member]
Components of net periodic benefit cost
Service Cost	5	11	18	36
Interest cost	24	23	75	71
Annual ESOP allocation	0	0	0	0
Expected return on plan assets	(27)	(25)	(83)	(76)
Amortization of transition and prior service costs (credits)	2	1	7	3
Amortization of actuarial loss	12	13	35	35
Net periodic benefit cost	16	23	52	69
International Pension Benefits [Member]
Components of net periodic benefit cost
Service Cost	6	4	16	13
Interest cost	9	9	28	26
Annual ESOP allocation	0	0	0	0
Expected return on plan assets	(7)	(7)	(21)	(19)
Amortization of transition and prior service costs (credits)	0	1	2	1
Amortization of actuarial loss	2	2	7	7
Net periodic benefit cost	10	9	32	28
Other Retiree Benefits [Member]
Components of net periodic benefit cost
Service Cost	2	3	8	10
Interest cost	8	9	29	30
Annual ESOP allocation	0	(1)	(1)	(5)
Expected return on plan assets	(1)	(1)	(2)	(2)
Amortization of transition and prior service costs (credits)	0	0	3	0
Amortization of actuarial loss	3	4	12	11
Net periodic benefit cost	$ 12	$ 14	$ 49	$ 44

XML

Retirement Plans and Other Retiree Benefits

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Retirement Plans and Other Retiree Benefits

Retirement Plans and Other Retiree Benefits

Components of net periodic benefit cost for the three and nine months endedSeptember 30, 2011 and 2010 were as follows: 

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended September 30,
	2011			2010			2011			2010			2011			2010
Service cost	$	5		$	11		$	6		$	4		$	2		$	3
Interest cost	24			23			9			9			8			9
Annual ESOP allocation	—			—			—			—			—			(1		)
Expected return on plan assets	(27		)	(25		)	(7		)	(7		)	(1		)	(1		)
Amortization of transition and prior service costs (credits)	2			1			—			1			—			—
Amortization of actuarial loss	12			13			2			2			3			4
Net periodic benefit cost	$	16		$	23		$	10		$	9		$	12		$	14

	Pension Benefits												Other Retiree Benefits
	United States						International
	Nine Months Ended September 30,
	2011			2010			2011			2010			2011			2010
Service cost	$	18		$	36		$	16		$	13		$	8		$	10
Interest cost	75			71			28			26			29			30
Annual ESOP allocation	—			—			—			—			(1		)	(5		)
Expected return on plan assets	(83		)	(76		)	(21		)	(19		)	(2		)	(2		)
Amortization of transition and prior service costs (credits)	7			3			2			1			3			—
Amortization of actuarial loss	35			35			7			7			12			11
Net periodic benefit cost	$	52		$	69		$	32		$	28		$	49		$	44

For the nine months ended September 30, 2011 and 2010 the Company made voluntary contributions of $178 and $35, respectively, to its U.S. postretirement plans.

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Certain prior year amounts have been reclassified to conform to the current year presentation.

For a complete set of financial notes, including the significant accounting policies of Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”), refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2010, filed with the Securities and Exchange Commission.

XML

Inventories

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Inventories

Inventories

Inventories by major class are as follows:

	September 30, 2011		December 31, 2010
Raw materials and supplies	$	324	$	295
Work-in-process	60		50
Finished goods	952		877
Total Inventories	$	1,336	$	1,222

XML

Earnings Per Share (Details) (USD $) In Millions, except Share data	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010	Dec. 29, 2010
Income [Abstract]
Net income (Loss) attributable to Colgate-Palmolive Company	$ 643	$ 619	$ 1,841	$ 1,579
Preferred dividends	0	(9)	0	(25)
Basic EPS	643	610	1,841	1,554
Convertible preference stock	0	9	0	25
Diluted EPS	$ 643	$ 619	$ 1,841	$ 1,579
Shares [Abstract]
Basic EPS (in shares)	486,700,000	486,000,000	489,900,000	489,900,000
Stock options and restricted stock (in shares)	3,800,000	3,800,000	3,500,000	4,700,000
Convertible preference stock (in shares)	0	19,700,000	0	20,100,000
Diluted EPS (in shares)	490,500,000	509,500,000	493,400,000	514,700,000
Per Share [Abstract]
Basic EPS (in dollars per share)	$ 1.32	$ 1.26	$ 3.76	$ 3.17
Diluted EPS (in dollars per share)	$ 1.31	$ 1.21	$ 3.73	$ 3.07
Average number of anti-dilutive shares (in shares)	1,202,090	4,248,553	422,263	49,904
Preference stock retired (in shares)					2,405,192
Common stock converted (in shares)					19,241,536

XML

Shareholders' Equity

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Shareholders' Equity

Shareholders’ Equity

Changes in the components of Shareholders’ Equity for the nine months endedSeptember 30, 2011 are as follows:

	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2010	$	733	$	1,132		$	(99	)	$	(11,305	)	$	14,329		$	(2,115	)	$	142
Net income												1,841						88
Other comprehensive income, net of tax															(84		)	(3		)
Dividends												(826		)				(24		)
Stock-based compensation expense			102
Shares issued for stock options			75						222
Shares issued for restricted stock awards			(49		)				49
Treasury stock acquired									(1,386		)
Other			8			40
Balance, September 30, 2011	$	733	$	1,268		$	(59	)	$	(12,420	)	$	15,344		$	(2,199	)	$	203

Accumulated Other comprehensive income (loss), as reflected in the Condensed Consolidated Balance Sheets, primarily consists of cumulative foreign currency translation adjustments and unrecognized pension and other retiree benefit costs. Refer to Note 6 for the components of Other comprehensive income (loss).

XML

Inventories (Details) (USD $) In Millions	Sep. 30, 2011	Dec. 31, 2010
Inventory, Net [Abstract]
Raw materials and supplies	$ 324	$ 295
Work-in-process	60	50
Finished Goods	952	877
Total Inventory	$ 1,336	$ 1,222

XML

Contingencies (Details) (USD $) In Millions	Sep. 30, 2011
Contingencies [Abstract]
Range of reasonably possible losses, minimum	$ 0
Range of reasonably possible losses, maximum	250
Brazilian internal revenue authority, matter 1	113
Brazilian internal revenue authority, matter 2	67
European competition matters - Swiss competition law authority	5
European competition matters - Spanish competition law authority	3
European competition matters - Italian competition law authority	$ 3

XML

Comprehensive Income (Details) (USD $) In Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Components Of Comprehensive Income [Line Items]
Net income including noncontrolling interests	$ 676	$ 645	$ 1,929	$ 1,662
Net income (Loss) attributable to Colgate-Palmolive Company	643	619	1,841	1,579
Net income (Loss) attributable to noncontrolling interests	33	26	88	83
Other Comprehensive Income (Loss), Net of Tax:
Cumulative translation adjustment	(483)	311	(186)	129
Retirement Plan and other retiree benefit adjustments	29	(332)	57	(310)
Gains (losses) on cash flow hedges	0	(3)	(4)	(7)
Other	(2)	(5)	46	(21)
Total Other comprehensive income (loss), net of tax	(456)	(29)	(87)	(209)
Comprehensive income	220	616	1,842	1,453
Defined Benefit Plan, Plan Amendment [Abstract]
Impact From Remeasurement Of Benefit Obligations And Assets Of Each Affected Plan Pre Tax		(550)
Impact From Remeasurement Of Benefit Obligations And Assets Of Each Affected Plan After Tax		(344)
Colgate-Palmolive Company [Member]
Components Of Comprehensive Income [Line Items]
Net income (Loss) attributable to Colgate-Palmolive Company	643	619	1,841	1,579
Other Comprehensive Income (Loss), Net of Tax:
Cumulative translation adjustment	(478)	307	(183)	126
Retirement Plan and other retiree benefit adjustments	29	(332)	57	(310)
Gains (losses) on cash flow hedges	0	(3)	(4)	(7)
Other	(2)	(5)	46	(21)
Total Other comprehensive income (loss), net of tax	(451)	(33)	(84)	(212)
Comprehensive Income	192	586	1,757	1,367
Noncontrolling Interests [Member]
Components Of Comprehensive Income [Line Items]
Net income (Loss) attributable to noncontrolling interests	33	26	88	83
Other Comprehensive Income (Loss), Net of Tax:
Cumulative translation adjustment	(5)	4	(3)	3
Retirement Plan and other retiree benefit adjustments	0	0	0	0
Gains (losses) on cash flow hedges	0	0	0	0
Other	0	0	0	0
Total Other comprehensive income (loss), net of tax	(5)	4	(3)	3
Comprehensive Income	$ 28	$ 30	$ 85	$ 86

XML

Acquisitions and Divestitures (Tables)

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Acquisition purchase price allocation

Total purchase price consideration of $960 has been allocated on a preliminary basis to the net assets acquired based on their respective estimated fair values at June 20, 2011, as follows:

Recognized amounts of assets acquired and liabilities assumed:
Inventories	$	21
Property, plant and equipment, net	7
Other intangible assets, net	605
Goodwill, net	411
Accrued income taxes	(80		)
Long-term other liabilities	(4		)
Fair value of net assets acquired	$	960

XML

Comprehensive Income

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Comprehensive Income

Comprehensive Income

The following are components of comprehensive income:

	Three Months Ended
	September 30, 2011									September 30, 2010
	Colgate-Palmolive Company			Noncontrolling interests			Total			Colgate-Palmolive Company			Noncontrolling interests		Total
Net income	$	643		$	33		$	676		$	619		$	26	$	645
Other comprehensive income (loss), net of tax:
Cumulative translation adjustment	(478		)	(5		)	(483		)	307			4		311
Retirement Plan and other retiree benefit adjustments	29			—			29			(332		)	—		(332		)
Gains (losses) on cash flow hedges	—			—			—			(3		)	—		(3		)
Other	(2		)	—			(2		)	(5		)	—		(5		)
Total Other comprehensive income (loss), net of tax	$	(451	)	$	(5	)	$	(456	)	$	(33	)	$	4	$	(29	)
Comprehensive income	$	192		$	28		$	220		$	586		$	30	$	616

	Nine Months Ended
	September 30, 2011									September 30, 2010
	Colgate-Palmolive Company			Noncontrolling interests			Total			Colgate-Palmolive Company			Noncontrolling interests		Total
Net income	$	1,841		$	88		$	1,929		$	1,579		$	83	$	1,662
Other comprehensive income (loss), net of tax:
Cumulative translation adjustment	(183		)	(3		)	(186		)	126			3		129
Retirement Plan and other retiree benefit adjustments	57			—			57			(310		)	—		(310		)
Gains (losses) on cash flow hedges	(4		)	—			(4		)	(7		)	—		(7		)
Other	46			—			46			(21		)	—		(21		)
Total Other comprehensive income (loss), net of tax	$	(84	)	$	(3	)	$	(87	)	$	(212	)	$	3	$	(209	)
Comprehensive income	$	1,757		$	85		$	1,842		$	1,367		$	86	$	1,453

During the third quarter of 2010, the Company amended certain provisions of its defined benefit, defined contribution and retiree medical plans in the U.S. As a result, the Company was required to remeasure the benefit obligations and assets of each affected plan as of the amendment date, September 1, 2010. The impact from the remeasurement was a charge of $550 ($344 aftertax) to Other comprehensive income (loss), net, as reflected in the table above, primarily due to the 100 basis point reduction in the discount rate since December 31, 2009. The incremental impact to the Company’s net income due to the plan amendments for the remainder of 2010 was not significant.

XML

Comprehensive Income (Tables)

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Components of comprehensive income

The following are components of comprehensive income:

	Three Months Ended
	September 30, 2011									September 30, 2010
	Colgate-Palmolive Company			Noncontrolling interests			Total			Colgate-Palmolive Company			Noncontrolling interests		Total
Net income	$	643		$	33		$	676		$	619		$	26	$	645
Other comprehensive income (loss), net of tax:
Cumulative translation adjustment	(478		)	(5		)	(483		)	307			4		311
Retirement Plan and other retiree benefit adjustments	29			—			29			(332		)	—		(332		)
Gains (losses) on cash flow hedges	—			—			—			(3		)	—		(3		)
Other	(2		)	—			(2		)	(5		)	—		(5		)
Total Other comprehensive income (loss), net of tax	$	(451	)	$	(5	)	$	(456	)	$	(33	)	$	4	$	(29	)
Comprehensive income	$	192		$	28		$	220		$	586		$	30	$	616

	Nine Months Ended
	September 30, 2011									September 30, 2010
	Colgate-Palmolive Company			Noncontrolling interests			Total			Colgate-Palmolive Company			Noncontrolling interests		Total
Net income	$	1,841		$	88		$	1,929		$	1,579		$	83	$	1,662
Other comprehensive income (loss), net of tax:
Cumulative translation adjustment	(183		)	(3		)	(186		)	126			3		129
Retirement Plan and other retiree benefit adjustments	57			—			57			(310		)	—		(310		)
Gains (losses) on cash flow hedges	(4		)	—			(4		)	(7		)	—		(7		)
Other	46			—			46			(21		)	—		(21		)
Total Other comprehensive income (loss), net of tax	$	(84	)	$	(3	)	$	(87	)	$	(212	)	$	3	$	(209	)
Comprehensive income	$	1,757		$	85		$	1,842		$	1,367		$	86	$	1,453

XML

Venezuela (Details) In Millions, unless otherwise specified	3 Months Ended	9 Months Ended		12 Months Ended
	Mar. 31, 2010 USD ($)	Sep. 30, 2011 USD ($)	Sep. 30, 2010 USD ($)	Dec. 31, 2010 USD ($)	Jan. 02, 2011	Jan. 08, 2010	Sep. 30, 2011 US Dollar-Linked, Devaluation-Protected Bonds Issued By Venezuelan Government [Member] USD ($)
Notes to Financial Statements [Abstract]
Venezuela hyperinflationary transition charge	$ 271	$ 0	$ 271
Charge for the premium paid to acquire USD cash	(150)
Charge for the premium paid to acquire USD cash	(152)
Gain for the premium paid on USD payables	31
Official currency exchange rate for Venezuela prior to devaluation						2.15
Official currency exchange rate in Venezuela for essential goods beginning January 8, 2010						2.60
Official currency exchange rate in Venezuela for non-essential goods beginning January 8, 2010						4.30
One-time pretax gain due to Venezuela currency devaluation			46
One-time aftertax gain due to currency devaluation			59
Official currency exchange rate in Venezuela for essential goods abolished effective January 1, 2011					2.60
Aftertax loss related to remeasurement				36
Percentage of consolidated Net sales represented by CP Venezuela (in hundredths)		5.00%
CP Venezuela's bolivar fuerte-denominated monetary net asset position		277
Schedule of Available-for-sale Securities [Line Items]
Fair value							$ 233

XML

Shareholders' Equity (Details) (USD $) In Millions	3 Months Ended		9 Months Ended				9 Months Ended					3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011 Common Stock [Member]	Dec. 31, 2010 Common Stock [Member]	Sep. 30, 2011 Additional Paid-In Capital [Member]	Sep. 30, 2011 Unearned Compensation [Member]	Sep. 30, 2011 Treasury Stock [Member]	Sep. 30, 2011 Retained Earnings [Member]	Sep. 30, 2011 Accumulated Other Comprehensive Income (Loss) [Member]	Sep. 30, 2011 Noncontrolling Interests [Member]	Sep. 30, 2010 Noncontrolling Interests [Member]	Sep. 30, 2011 Noncontrolling Interests [Member]	Sep. 30, 2010 Noncontrolling Interests [Member]
Changes in Shareholders' Equity [Roll Forward]
Balance			$ 2,817		$ 733	$ 733	$ 1,132	$ (99)	$ (11,305)	$ 14,329	$ (2,115)			$ 142
Net income (Loss) attributable to Colgate-Palmolive Company	643	619	1,841	1,579						1,841
Net income (Loss) attributable to noncontrolling interests	33	26	88	83								33	26	88	83
Other comprehensive income, net of tax	(456)	(29)	(87)	(209)							(84)	(5)	4	(3)	3
Dividends										(826)				(24)
Stock-based compensation expense							102
Shares issued for stock options							75		222
Stock issued for restricted stock awards							(49)		49
Treasury stock acquired									(1,386)
Other							8	40
Balance	$ 2,870		$ 2,870		$ 733	$ 733	$ 1,268	$ (59)	$ (12,420)	$ 15,344	$ (2,199)	$ 203		$ 203

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) In Millions	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Operating Activities
Net income including noncontrolling interests	$ 1,929	$ 1,662
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	315	278
Restructuring, net of cash	130	0
Venezuela hyperinflationary transition charge	0	271
Gain before tax on sales of non-core product lines	(207)	0
Voluntary benefit plan contributions	(178)	(35)
Stock-based compensation expense	102	101
Deferred income taxes	134	91
Cash effects of changes in:
Receivables	(127)	(56)
Inventories	(147)	(63)
Accounts payable and other accruals	62	(95)
Other non-current assets and liabilities	44	89
Net cash provided by operations	2,057	2,243
Investing Activities
Capital expenditures	(324)	(318)
Sale of property and non-core product lines	241	3
Purchases of marketable securities and investments	(108)	(211)
Proceeds from sale of marketable securities and investments	173	94
Payment for acquisitions, net of cash acquired	(972)	0
Other	(8)	(6)
Net cash used in investing activities	(998)	(438)
Financing Activities
Principal payments on debt	(2,720)	(3,469)
Proceeds from issuance of debt	4,074	3,709
Dividends paid	(850)	(804)
Purchases of treasury shares	(1,386)	(1,385)
Proceeds from exercise of stock options and excess tax benefits	316	204
Net Cash Provided by (Used in) Financing Activities	(566)	(1,745)
Effect of exchange rate changes on Cash and cash equivalents	(38)	(6)
Net increase (decrease) in Cash and cash equivalents	455	54
Cash and Cash Equivalents at beginning of the period	490	600
Cash and Cash Equivalents at end of the period	945	654
Supplemental Cash Flow Information
Income taxes paid	$ 769	$ 854

XML

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Earnings Per Share

	Three Months Ended
	September 30, 2011					September 30, 2010
	Income		Shares (millions)	Per Share		Income			Shares (millions)	Per Share
Net income attributable to Colgate-Palmolive Company	$	643				$	619
Preferred dividends	—					(9		)
Basic EPS	643		486.7	$	1.32	610			486.0	$	1.26
Stock options and restricted stock			3.8						3.8
Convertible preference stock	—		—			9			19.7
Diluted EPS	$	643	490.5	$	1.31	$	619		509.5	$	1.21

For the three months ended September 30, 2011 and 2010, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 1,202,090 and 4,248,553, respectively.

	Nine Months Ended
	September 30, 2011					September 30, 2010
	Income		Shares (millions)	Per Share		Income			Shares (millions)	Per Share
Net income attributable to Colgate-Palmolive Company	$	1,841				$	1,579
Preferred dividends	—					(25		)
Basic EPS	1,841		489.9	$	3.76	1,554			489.9	$	3.17
Stock options and restricted stock			3.5						4.7
Convertible preference stock	—		—			25			20.1
Diluted EPS	$	1,841	493.4	$	3.73	$	1,579		514.7	$	3.07

For the nine months endedSeptember 30, 2011 and 2010, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 422,263 and 49,904, respectively.

XML

Segment Information (Tables)

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Net Sales and Operating Profit by Segment

Net sales and Operating profit by segment were as follows:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2011			2010			2011			2010
Net sales
Oral, Personal and Home Care
North America	$	776		$	753		$	2,238		$	2,274
Latin America	1,243			1,069			3,571			3,130
Europe/South Pacific	972			821			2,661			2,415
Greater Asia/Africa	855			779			2,484			2,239
Total Oral, Personal and Home Care	3,846			3,422			10,954			10,058
Pet Nutrition	537			521			1,608			1,528
Total Net sales	$	4,383		$	3,943		$	12,562		$	11,586
Operating profit
Oral, Personal and Home Care
North America	$	213		$	224		$	599		$	668
Latin America	364			332			1,050			975
Europe/South Pacific	196			197			551			572
Greater Asia/Africa	202			195			604			573
Total Oral, Personal and Home Care	975			948			2,804			2,788
Pet Nutrition	127			138			408			413
Corporate	(67		)	(128		)	(294		)	(617		)
Total Operating profit	$	1,035		$	958		$	2,918		$	2,584

XML

Use of Estimates

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Use of Estimates

Use of Estimates

Provision for certain expenses, including income taxes, media advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales.

XML

Fair Value Measurements and Financial Instruments

9 Months Ended

Sep. 30, 2011

Financial Instruments and Fair Value Measurements [Abstract]

Financial Instruments and Fair Value Measurements

Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to credit losses in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely as it is the Company’s policy to contract only with diverse, highly rated counterparties.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, supplier agreements, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented.

The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). Foreign currency contracts consist of forward, option and swap contracts utilized to hedge a portion of the Company’s foreign currency purchases, assets and liabilities created in the normal course of business as well as the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in the Company’s operations. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.

The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at September 30, 2011 and December 31, 2010:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		9/30/11		12/31/10			9/30/11		12/31/10
Interest rate swap contracts	Other current assets & Other assets	$	45	$	22	Other liabilities	$	—	$	7
Foreign currency contracts	Other current assets	8		10		Other accruals	8		10
Commodity contracts	Other current assets	—		4		Other accruals	3		—
Total designated		$	53	$	36		$	11	$	17
Derivatives not designated
Foreign currency contracts	Other assets	$	2	$	—	Other accruals	$	—	$	2
Total not designated		$	2	$	—		$	—	$	2
Total derivative instruments		$	55	$	36		$	11	$	19
Other financial instruments
Marketable securities	Other current assets	$	72	$	74
Available-for-sale securities	Other assets	233		228
Total other financial instruments		$	305	$	302

The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of September 30, 2011 and December 31, 2010. The estimated fair value of the Company’s long-term debt, including the current portion, as of September 30, 2011 and December 31, 2010, was $5,020 and $3,613, respectively, and the related carrying value was $4,689 and $3,376, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

Fair value hedges

The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting loss or gain on the hedged item are recognized in current earnings. The impact of foreign currency contracts is recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest expense, net.

During the second quarter of 2011, the Company issued $250 of six-year notes at a fixed rate of 2.625% and $250 of three-year notes at a fixed rate of 1.250% under the Company’s shelf registration statement. The Company simultaneously entered into interest rate swaps to effectively convert the fixed rate of the notes to a variable rate.

Activity related to fair value hedges recorded during the three-month and nine-month periods ended September 30, 2011 and 2010 was as follows:

	2011									2010
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at September 30	$	619		$	1,288		$	1,907		$	1,080		$	600		$	1,680
Three-months ended September 30:
Gain (loss) on derivative	—			22			22			26			4			30
Gain (loss) on hedged items	—			(22		)	(22		)	(26		)	(4		)	(30		)
Nine-months ended September 30:
Gain (loss) on derivative	6			30			36			22			13			35
Gain (loss) on hedged items	(6		)	(30		)	(36		)	(22		)	(13		)	(35		)

Cash flow hedges

All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (OCI) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.

Activity related to cash flow hedges recorded during the three-month and nine-month periods ended September 30, 2011 and 2010 was as follows:

	2011									2010
	Foreign Currency Contracts			Commodity Contracts			Total			Foreign Currency Contracts			Commodity Contracts			Total
Notional Value at September 30	$	326		$	32		$	358		$	292		$	16		$	308
Three-months ended September 30:
Gain (loss) recognized in OCI	(2		)	(2		)	(4		)	(11		)	5			(6		)
Gain (loss) reclassified into Cost of sales	(5		)	1			(4		)	(3		)	—			(3		)
Nine-months ended September 30:
Gain (loss) recognized in OCI	(9		)	(2		)	(11		)	(10		)	2			(8		)
Gain (loss) reclassified into Cost of sales	(13		)	6			(7		)	—			(1		)	(1		)

The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is expected to be recognized in Cost of sales within the next twelve months.

Net investment hedges

The Company has designated certain foreign currency forward and option contracts and certain foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Currency translation adjustments within OCI, along with the offsetting gain or loss on the hedged items.

Activity related to net investment hedges recorded during the three-month and nine-month periods ended September 30, 2011 and 2010 was as follows:

	2011									2010
	Foreign Currency Contracts			Foreign Currency Debt			Total			Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at September 30	$	32		$	348		$	380		$	76		$	279		$	355
Three-months ended September 30:
Gain (loss) on instruments	2			23			25			(10		)	(31		)	(41		)
Gain (loss) on hedged items	(2		)	(23		)	(25		)	10			31			41
Nine-months ended September 30:
Gain (loss) on instruments	(8		)	(10		)	(18		)	(6		)	3			(3		)
Gain (loss) on hedged items	8			10			18			6			(3		)	3

Derivatives Not Designated as Hedging Instruments

Derivatives not designated as hedging instruments for each period consist of a cross-currency swap that serves as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item are recognized in Other (income) expense, net for each period. The cross-currency swap outstanding at December 31, 2010 was settled during the second quarter of 2011, resulting in a realized loss of $6 which was offset by a corresponding gain on an underlying deposit. A new cross-currency swap with similar terms and an underlying foreign currency deposit was entered into during June 2011.

Activity related to these contracts during the three-month and nine-month periods ended September 30, 2011 and 2010 was as follows:

	2011			2010
	Cross-currency Swap			Cross-currency Swap
Notional Value at September 30	$	96		$	90
Three-months ended September 30:
Gain (loss) on instrument	2			(5		)
Gain (loss) on hedged item	(2		)	5
Nine-months ended September 30:
Gain (loss) on instrument	(2		)	1
Gain (loss) on hedged item	2			(1		)

Other Financial Instruments

Marketable securities consist of bank deposits with original maturities greater than 90 days (Level 1 valuation).

Available-for-sale securities consist of the fixed income investments discussed below.

In 2010, the Company invested in a portfolio of euro-denominated investment grade fixed income securities, including corporate bonds, with maturities generally ranging from one to three years. During the second quarter of 2011, the Company liquidated the investment portfolio as part of the cash management strategy to fund the acquisition of the Sanex business. The portfolio was considered a Level 1 investment as all of the securities had quoted prices on an active exchange with daily liquidity. At December 31, 2010, the portfolio’s fair value was $132 and was reported in Other assets in the Condensed Consolidated Balance Sheet.

Through its subsidiary in Venezuela, the Company has also invested in U.S. dollar-linked, devaluation-protected bonds issued by the Venezuelan government. As of December 31, 2010, these bonds were considered Level 3 as there was no trading activity in the market at the end of 2010 and their value was determined using unobservable inputs reflecting the Company’s own assumptions. As of September 30, 2011, these bonds are actively traded and, therefore, are considered Level 2 as their value is determined based upon observable market-based inputs or unobservable inputs that are corroborated by market data.

The following table presents a reconciliation of the Venezuelan investments at fair value for the nine months ended September 30:

	2011		2010
Beginning balance as of January 1	$	96	$	46
Unrealized gain (loss) on investment	60		(19		)
Purchases and sales during the period	77		23
Ending balance as of September 30	$	233	$	50

As a result of the Venezuelan government’s elimination of the two-tier exchange rate structure effective January 1, 2011, these bonds have revalued and the Company recorded an unrealized gain of $62 in the first quarter of 2011. For further information regarding Venezuela, refer to Note 12 below.

XML

Segment Information (Details) (USD $) In Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Mar. 31, 2010	Sep. 30, 2011	Sep. 30, 2010
Notes to Financial Statements [Abstract]
Venezuela hyperinflationary transition charge			$ 271	$ 0	$ 271
Pretax gain from the sale of Colombia brands	207			207	0
Costs associated with various Business Realignment and other cost-saving initiatives	168			168
Pretax costs related to sale of land	7			7
Segment Reporting Information [Line Items]
Total Net sales	4,383	3,943		12,562	11,586
Total Operating profit	1,035	958		2,918	2,584
North America [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	776	753		2,238	2,274
Total Operating profit	213	224		599	668
Latin America [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	1,243	1,069		3,571	3,130
Total Operating profit	364	332		1,050	975
Europe/South Pacific [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	972	821		2,661	2,415
Total Operating profit	196	197		551	572
Greater Asia/Africa [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	855	779		2,484	2,239
Total Operating profit	202	195		604	573
Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	3,846	3,422		10,954	10,058
Total Operating profit	975	948		2,804	2,788
Pet Nutrition [Member]
Segment Reporting Information [Line Items]
Total Net sales	537	521		1,608	1,528
Total Operating profit	127	138		408	413
Corporate [Member]
Segment Reporting Information [Line Items]
Total Operating profit	$ (67)	$ (128)		$ (294)	$ (617)

XML

Shareholders' Equity (Tables)

9 Months Ended

Sep. 30, 2011

Notes to Financial Statements [Abstract]

Shareholders' Equity

Changes in the components of Shareholders’ Equity for the nine months endedSeptember 30, 2011 are as follows:

	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2010	$	733	$	1,132		$	(99	)	$	(11,305	)	$	14,329		$	(2,115	)	$	142
Net income												1,841						88
Other comprehensive income, net of tax															(84		)	(3		)
Dividends												(826		)				(24		)
Stock-based compensation expense			102
Shares issued for stock options			75						222
Shares issued for restricted stock awards			(49		)				49
Treasury stock acquired									(1,386		)
Other			8			40
Balance, September 30, 2011	$	733	$	1,268		$	(59	)	$	(12,420	)	$	15,344		$	(2,199	)	$	203

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (USD $) In Millions, except Per Share data	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) [Abstract]
Net sales	$ 4,383	$ 3,943	$ 12,562	$ 11,586
Cost of sales	1,921	1,599	5,365	4,732
Gross profit	2,462	2,344	7,197	6,854
Selling, general and administrative expenses	1,489	1,391	4,314	4,038
Other (income) expense, net	(62)	(5)	(35)	232
Operating profit	1,035	958	2,918	2,584
Interest expense, net	10	13	37	43
Income before income taxes	1,025	945	2,881	2,541
Provision for income taxes	349	300	952	879
Net income including noncontrolling interests	676	645	1,929	1,662
Less: Net income attributable to noncontrolling interests	33	26	88	83
Net income attributable to Colgate-Palmolive Company	$ 643	$ 619	$ 1,841	$ 1,579
Earnings per common share, basic (in dollars per share)	$ 1.32	$ 1.26	$ 3.76	$ 3.17
Earnings per common share, diluted (in dollars per share)	$ 1.31	$ 1.21	$ 3.73	$ 3.07
Dividends declared per common share (in dollars per share)	$ 0.58	$ 0.53	$ 1.69	$ 1.50

XML

Financial Instruments and Fair Value Measurements (Details 2) (USD $) In Millions, unless otherwise specified	Sep. 30, 2011 Carrying Value [Member]	Dec. 31, 2010 Carrying Value [Member]	Sep. 30, 2011 Fair Value, Inputs, Level 2 [Member]	Dec. 31, 2010 Fair Value, Inputs, Level 2 [Member]	Jun. 30, 2011 Notes Fixed Rate 2.625% [Member]	Jun. 30, 2011 Notes Fixed Rate 1.25% [Member]
Debt Instrument [Line Items]
Long-term debt	$ 4,689	$ 3,376	$ 5,020	$ 3,613
Face amount					$ 250	$ 250
Term of notes					6 years	3 years
Interest rate on notes issued (in hundredths)					2.625%	1.25%

XML

Financial Instruments and Fair Value Measurements (Details 3) (USD $) In Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2011	Jun. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Activity related to fair value hedges [Abstract]
Notional Value	$ 1,907		$ 1,680	$ 1,907	$ 1,680
Gain (loss) on derivative	22		30	36	35
Gain (loss) on hedged items	(22)		(30)	(36)	(35)
Activity related to cash flow hedges [Abstract]
Notional Value	358		308	358	308
Gain (loss) recognized in OCI	(4)		(6)	(11)	(8)
Gain (loss) reclassified into Cost of sales	(4)		(3)	(7)	(1)
Activity related to net investment hedges [Abstract]
Notional Value	380		355	380	355
Gain (loss) on instruments	25		(41)	(18)	(3)
Gain (loss) on hedged items	(25)		41	18	3
Interest Rate Swap Contracts [Member]
Activity related to fair value hedges [Abstract]
Notional Value	1,288		600	1,288	600
Gain (loss) on derivative	22		4	30	13
Gain (loss) on hedged items	(22)		(4)	(30)	(13)
Foreign Currency Contracts [Member]
Activity related to fair value hedges [Abstract]
Notional Value	619		1,080	619	1,080
Gain (loss) on derivative	0		26	6	22
Gain (loss) on hedged items	0		(26)	(6)	(22)
Activity related to cash flow hedges [Abstract]
Notional Value	326		292	326	292
Gain (loss) recognized in OCI	(2)		(11)	(9)	(10)
Gain (loss) reclassified into Cost of sales	(5)		(3)	(13)	0
Activity related to net investment hedges [Abstract]
Notional Value	32		76	32	76
Gain (loss) on instruments	2		(10)	(8)	(6)
Gain (loss) on hedged items	(2)		10	8	6
Commodity Contracts [Member]
Activity related to cash flow hedges [Abstract]
Notional Value	32		16	32	16
Gain (loss) recognized in OCI	(2)		5	(2)	2
Gain (loss) reclassified into Cost of sales	1		0	6	(1)
Foreign Currency Denominated Debt [Member]
Activity related to net investment hedges [Abstract]
Notional Value	348		279	348	279
Gain (loss) on instruments	23		(31)	(10)	3
Gain (loss) on hedged items	(23)		31	10	(3)
Cross-Currency Swap [Member]
Activity related to derivatives not designated as hedging instruments [Abstract]
Notional Value	96		90	96	90
Gain (loss) on instrument	2		(5)	(2)	1
Gain (loss) on hedged item	(2)		5	2	(1)
Net realized loss of a cross-currency swap		$ (6)